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ABSTRACT 
EFFECTS OF BIOLOGICAL COMPOUND TURKISH PROPOLIS 
EXTRACT ON BREAST CANCER CELLS 
 
Deniz UĞURLU 
M.S. in Molecular Biology and Genetics 
Supervisor: Assoc. Prof. Dr. Işık YULUĞ  
August, 2013 
 
Propolis is a resinous compound which is collected from various plants then 
combined with wax and bee enzymes by worker bees. There are many studies 
conducted on propolis or its active components aiming to find new treatment 
possibilities in diverse research fields such as immunology, infectious diseases, 
allergy, diabetes, ulcers, and oncology. Chemical analysis indicated that propolis is a 
multicomponent mixture of various compounds with prevalence of flavonoids and 
phenolic acids. Therefore it  is important to investigate the propolis extract 
mechanisms of action in order to predict possible cytotoxic and may be therapeutic 
effects for cancer. The most common propolis extract is ethanol extract of propolis 
(EEP) whereas Turkish researchers were able to extract the propolis with dimethyl 
sulfoxide (DMSO) which can maximize the penetration of compounds from propolis 
to the cells as well as DMSO is a good solvent for flavonols (one of the most 
common compound in propolis). There are many studies conducted on propolis or 
its active components for treatment of cancer which reveals the potential of this 
biological compound in the development of novel anti-cancerous agents. However, 
anti-cancer activity of DMSO extract of Turkish propolis (DEP) on human breast 
cancer has not been investigated yet. The aim of this study was to investigate the 
anti-cancer effects of DMSO extract of Turkish propolis (DEP) on cancer cells. 
Inhibitory effects of propolis extracts collected from different regions of Turkey 
were analyzed on the growth of the human breast carcinoma cells. Two different 
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propolis extracts were used to determine their cytotoxic effects of breast carcinoma 
cell lines using SRB staining and IC50 values were determined. The results showed 
that propolis is cytotoxic in dose-dependent manner (IC50 value of diverse from 25 
ug/ml to 123 ug/ml). Real time monitoring (xCELLigence system) of propolis treated 
cells confirmed the cytotoxic effect of propolis, since increasing concentrations of 
propolis decreased the cell number in a dose- and  cell line- dependent way. 
Furthermore, propolis treatment induces apoptosis in breast carcinoma cell lines. 
Propolis treated cells changed their adherent morphology to round cells and 
detached from the surface. Hoechst 33258 staining of propolis treated cells 
revealed the increasing number of cells displays DNA condensation. PARP-1, a 116 
kDa nuclear enzyme, is cleaved in fragments of 89 and 24 kDa during apoptosis. 
Western blot analysis was performed to detect the PARP-1 cleavage in propolis 
treated cells. Decrease in the full-length PARP-1 protein levels supports our 
hypothesis that propolis shows its cytotoxic effect at least partially through 
induction of apoptosis. The effect of propolis on cell cycle was analyzed  with flow 
cytometer after staining the cells with  Propidium iodide (PI). Increase in the G2/M 
cell cycle arrest was observed in propolis treated cells compare to control DMSO 
treated MDA-MB-231 cells.  In addition to cytotoxic effects, in vitro wound healing 
assay revealed that propolis treated MDA-MB-231 cells shows delayed invasion of 
the cells to the denuded area when compared to the DMSO control cells. In 
conclusion, propolis showed a cytotoxic effect on breast carcinoma cell lines by 
inducing apoptosis, G2/M arrest as well as delaying the invasion capacity of the cells 
which makes it a potent anti-tumorigenic compound that may be useful in cancer 
chemoprevention or therapy. 
 
 
Key words: Propolis, Breast Cancer, Cytotoxic, Apoptosis, xCELLigence, Scratch 
Assay. 
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ÖZET 
BİYOLOJİK BİLEŞKE TÜRK PROPOLİSİNİN MEME KANSERİ 
HÜCRELERİNE ETKİLERİ 
 
Deniz UĞURLU 
Moleküler Biyoloji ve Genetik, Yüksek Lisans 
Tez Yöneticisi: Doç. Dr. Işık YULUĞ  
Ağustos, 2013 
 
Propolis, işçi arılar tarafından çeşitli bitkilerden toplanıp balmumu ve arı 
enzimleriyle kombine edilen, reçine tipinde bir üründür. Propolis veya aktif 
bileşenleriyle ilgili olarak immünoloji, enfeksiyon hastalıkları, alerji, diyabet, ülser ve 
onkoloji gibi çeşitli araştırma alanlarında yeni tedavi olasılıkları bulmayı hedefleyen 
çok sayıda çalışma vardır. Kimyasal analizler propolisin flavonoidler ve fenolik 
asitlerle birlikte çeşitli bileşenlerin karışımı olduğunu göstermiştir. Bu nedenle olası 
toksik ve terapötik etkileri öngörmek açısından propolis ekstrelerinin etki 
mekanizmalarını incelemek önemlidir. En sık kullanılan propolis ekstresi propolisin 
etanol ekstresidir (EEP). Türk araştırmacılar propolis bileşenlerinin hücrelere 
penetrasyonunu maksimuma çıkartabilecek şekilde propolisin dimetil sülfoksit 
(DMSO) ile ekstresini elde edebilmişlerdir. DMSO, flavonoller (propolis içinde en sık 
bulunan bileşenlerden) için iyi bir solventtir. Propolis veya aktif bileşenlerinin kanser 
tedavisinde kullanımıyla ilgili olarak yapılmış ve bu biyolojik bileşenin yeni anti-
kanser ajanların geliştirilmesindeki potansiyelini gösteren çok sayıda çalışma vardır. 
Ancak Türk propolisinin DMSO ekstresinin (DEP) insan meme kanseri üzerindeki 
anti-kanser aktivitesi henüz incelenmemiştir. Bu çalışmanın amacı kanser hücreleri 
üzerinde Türk propolisinin DMSO ekstresinin (DEP) anti-kanser etkilerini 
araştırmaktır. Çalışmada Türkiye'nin çeşitli bölgelerinden toplanan propolisin insan 
meme karsinomu hücrelerinin büyümesi üzerindeki inhibe edici etkileri incelendi. 
SRB boyaması kullanılarak iki farklı propolis ekstresinin meme karsinomu hücre 
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hatları üzerindeki sitotoksik etkileri incelendi ve IC50 değerleri belirlendi. Sonuçlar 
propolisin doza bağımlı bir şekilde sitotoksik olduğunu gösterdi (IC50 değeri 25 ug/ml 
ile 123 ug/ml arasında değişmektedir). Propolis ile muamele edilen hücrelerin 
gerçek zamanlı incelenmesi (xCELLigence sistemi) propolis sitotoksik etkilerini 
doğruladı çünkü artan propolis konsantrasyonları hücre sayısını doza ve hücre 
hattına bağımlı bir şekilde azalttı. Ayrıca propolis tedavisi meme kanseri hücre 
hatlarında apoptozu indükledi. Muamele edilen hücrelerin adheran morfolojisi 
yuvarlak hücreler haline dönüştü ve Hoechst 33258 boyama yöntemi ile artan 
sayıda hücrede DNA kondansasyonu gösterdi. Apoptoz sırasında, 116 kDa bir 
nükleer enzim olan PARP-1, 89 ve 24 kDa büyüklüğündeki fragmanlara 
ayrılmaktadır. Propolis ile muamele edilen hücrelerde PARP-1 ayrılmasını saptamak 
üzere Western blot analizi yapıldı. Tam uzunlukta PARP-1 protein seviyelerinde 
azalma, propolisin sitotoksik etkisini en azından kısmen apoptoz indüksiyonu yoluyla 
gösterdiği hipotezimizi desteklemektedir. Propolisin hücre döngüsü üzerine etkisi, 
hücrelerin Propidium iyodür (PI) ile boyandıktan sonra bir akış sitometresi 
tarafından analiz edilmesiyle incelendi. Kontrol DMSO ile muamele edilmiş MDA-
MB-231 hücreleriyle karşılaştırıldığında propolis ile muamele edilen hücrelerde 
G2/M hücre döngüsü arestinde güçlü bir artış görüldü. Sitotoksik etkilere ilaveten, 
in vitro yara iyileşmesi testi, propolis ile muamele edilen MDA-MB-231 hücrelerinin 
DMSO kontrol hücreleriyle karşılaştırıldığında soyulmuş bölgeye hücre 
invasyonunda gecikme olduğu saptandı. Sonuç olarak, meme kanseri hücre 
hatlarında apoptoz ve G2/M arestini indükleyerek ve ayrıca hücrelerin invazyon 
kapasitesini geciktirerek gösterdiği sitotoksik etki sayesinde propolis kanser 
kemoterapisi veya önlenmesinde faydalı olabilecek güçlü bir anti-tümorijenik 
bileşendir.  
 
Anahtar Sözcükler: Propolis, Meme Kanseri, Sitotoksik, Apoptoz, xCELLigence, Yara 
İyileşmesi testi 
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1 INTRODUCTION 
 
1.1 Breast Cancer 
 
Malignant tumors can invade the surrounding cells or metastasize to other parts of 
body. It is defined as breast cancer when the malignant tumor starts in the cells of 
breast (cancer.org; American Cancer Society). Healthy breast consists of fat, 
connective tissue, blood and lymph vessels (Figure 1-1). 
 
 
Figure 1-1 Anatomy of breast (Harness, 2011). 
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Breast cancer is the most common cancer type and the leading cause of cancer 
death among women worldwide (Table 1.1). Increase in the age is the most 
important risk factor and BRCA1 & BRCA2 inherited mutations increase the risk 
(cancer.org; American Cancer Society). 
 
Table 1.1 The two most common types of new cancer cases and deaths by world 
area, 2008 (cancer.org; American Cancer Society). 
 
 
1.1.1 Classification of Breast Cancer 
 
Since breast consists of epithelial cells, almost all of the breast cancers are 
carcinomas. Some of them are adenocarcinomas if cancer starts from ducts or 
lobules of the breast which produces milk. Carcinoma in situ is the early stage of the 
cancer and this is referred to as non-invasive or pre-invasive (cancer.org; American 
Cancer Society).  On the other hand, infiltrating carcinomas are invasive and 
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constitutes more than 95% of all mammary carcinomas (Yoder, 2007). Both 
carcinomas can be ductal or lobular.  
Molecular classification is very important for breast cancer because of the 
heterogeneous nature of the cancer. Basal and luminal cells are the two distinct 
epithelial subtypes of mammary gland (Perou, 2000). Luminal subtype can be 
divided into Luminal A and Luminal B as their gene expression pattern (Sorlie, 2003). 
Also another subdivision came from Neve et. al. as Basal A and Basal B (Neve, 2006). 
Dawson et. al. introduced a novel categorization in recently published article. This 
categorization includes 10 “integrative clusters” which are generated from 
molecular information of genomic and transcriptomic features of breast cancer 
(Dawson, 2013). Categorization of Breast cancer is important for the sake of proper 
treatment to each subtype of breast cancer. Different drugs may affect a subtype of 
breast cancer which can be linked with its molecular properties. 
 
1.1.2 Breast Carcinoma Cell Lines 
 
BT-20 was the first breast carcinoma cell line to be established in 1958. Followed by 
MD Anderson series of breast carcinoma cell lines and the most famous one, MCF7 
was established by Michigan Cancer Foundation in 1973. Cell lines are good models 
of breast cancer research (Holliday, 2011). Classification of cell lines is also 
important to use the right cell line as model. For example, a specific kinase inhibitor 
was shown that it preferentially inhibits proliferation of luminal estrogen receptor-
positive human breast carcinoma cell lines (Finn, 2009). Different compounds may 
have selective effect on subtypes of breast cancer and this can be linked with its 
molecular properties of the subtype. Some of the characteristics of the breast 
carcinoma cell lines are summarized in the Table 1.2. 
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Table 1.2 Properties of Breast carcinoma cell lines. {* = amplified but not highly 
expressed, n/a = not available, wt = wild type, ER = estrogen receptor, PR = 
progesterone receptor, HER2[ERBB2] = Human Epidermal Growth Factor Receptor 
2} (Neve, 2006; Kao, 2009; Finn, 2009; Holliday, 2011). 
  Subtype ER status PR status HER2 status p53 mutation 
MCF10A Basal B negative negative immortalized +/- wt 
MCF12A Basal B negative negative n/a + 
CAMA-1 Luminal positive negative normal + 
MDA-MB 231 Basal 
B(Post-EMT) negative negative normal ++ mutant 
MDA-MB-453 Luminal negative negative amplified* - wt 
MDA-MB-468 Basal A negative negative normal + 
MCF7 Luminal A positive positive normal +/- wt 
T47D Luminal A positive positive normal ++ mutant 
MDA-MB-157 Basal 
B(Post-EMT) negative negative normal - 
HCC-1937 Basal A 
(Post-EMT) negative negative normal - 
BT-20 Basal A negative negative normal ++ wt 
MDA-MB-361 Luminal positive positive amplified - wt 
BT-474 Luminal B positive positive amplified + 
ZR-75-1 Luminal B positive negative normal - 
hTERT-HME1 Basal B negative n/a negative n/a 
 
 
1.2 Biological Compound Propolis 
 
From ancient times to today, humankind faced to reality of breast cancer and tried 
different treatments varies from organic supplies to surgical operations. We are still 
looking for a cure for cancer in general. If we assume that nature has a remedy for 
all problems, we should look for the remedy for treatment of breast cancer. In this 
case we are looking for it in a beehive where propolis comes from. 
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Propolis or bee glue is a yellow-brownish resinous compound which is collected 
from various plants and combined with wax and bee enzymes by worker bees. This 
mixture is used to smooth out hive walls, to protect bees from diseases because of 
its antiseptic features and also to embalm the carcasses of invader insects to avoid 
decomposition (Sforcin, 2011). The word propolis comes from a Greek origin which 
pro is ‘in front of’ or ‘at the entrance to’ and polis is city -in this case, hive- therefore 
propolis means that a material in defense of the hive (Castaldo, 2002). 
Using propolis as a medicine has a long history dating back to ancient times. For 
instance, Ancient Egyptians used propolis to embalm the cadavers and Ancient 
Greeks and Romans used propolis as an anti-inflammatory agent to heal wounds 
and ulcers. Also it was accepted as an official drug in London in 17th century 
(Salatino, 2011). Still, it is widely used among Balkan States. There are also studies 
that show propolis having no side effect to mice or human (Sforcin, 2007). Recently, 
there are many studies associated with propolis extracts aiming to find new 
treatment possibilities in diverse research fields such as immunology, oncology, 
infectious diseases, allergy, diabetes, ulcers, etc (Sforcin, 2011). 
Chemical composition of propolis varies by the geographical status and by the 
different races of honeybees. Different studies are going on with local propolis 
extracts such as Cuban, Brazilian, Chinese, Indian etc. (Monzote, 2012; Sforcin, 
2011; Sun, 2012; Thirugnanasampandan, 2012). Propolis is mainly composed of 
resins which comes from plants those honeybees collect from. Hence, propolis 
extracts from different geographical origin have a specific combination of chemicals 
that reflect the floral properties of the field (Salatino, 2011). Sibel Silici and 
Semiramis Kutluca showed that Turkish propolis collected form Erzurum region 
have a number of chemical compounds which were identified from propolis for the 
first time (Silici, 2005). 
Diversity of propolis has both advantages and disadvantages for the research. 
Distinct compounds found in propolis may have novel benefits for the drug 
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discoveries or they may construct a novel synergistic effect with regular compounds 
found in propolis. Major disadvantage would be the problem of standardization of 
propolis as a possible drug; however there are many ways to overcome this 
problem. The most common solution to standardize of propolis is to categorize 
propolis according to its chemical composition and source of plant. Six main types 
of propolis are poplar propolis, birch propolis, Brazilian green propolis, red propolis, 
pacific propolis and Canarian propolis (Bankova, 2005). When the standardization 
problem is defeated, the use of propolis is “safe and less toxic than many synthetic 
medicines” (Castaldo, 2002). 
 
1.2.1 Propolis Extracts 
 
Propolis extraction is made with alcoholic solvents or water, generally. The most 
common solvent is absolute ethanol, methanol and water follows it. While water 
extraction has 7% activity, alcoholic extractions can reach up to 28% activity. Also 
triglyceride extraction patent is held by Japanese researchers (Ashry, 2012). Since 
the chemical composition of propolis is very complex (propolis consist of more than 
300 components), solvent of the extraction method affects the activity of propolis. 
Different compounds in the mixture can solubilize in different solvents so that each 
extraction material gives different outcomes (Sforcin, 2007).  
Turkish researchers were able to extract the propolis with dimethyl sulfoxide 
(DMSO) which can dissolve both polar and nonpolar compounds (Aliyazicioglu, 
2005). DMSO maximizes the penetration of compounds to the cells as well as it is a 
good solvent for flavonols (one of the most common compound in propolis) (Cai, 
2011). According to one of the studies, DMSO extract of propolis (DEP) is richer in 
polyphenols and flavonoids than water extraction of propolis (WEP). They also claim 
that the antioxidant potentials of those two extracts are parallel with the total 
phenolic compounds in each extract (Barlak, 2011). 
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Propolis composition is highly variable considering the plant source, bee race, 
geographical and seasonal diversity. In general, propolis contains flavonoids such as 
chrysin, acacetin, apigenin, and phenolic acids like cinnamic acid, caffeic acid, etc 
(Table 1.3). Propolis also includes some vitamins and minerals as well as fatty acids 
(Khalil, 2006). Some of the researchers use the whole extract of propolis whereas 
others prefer to use active components of it. Even though using an individual 
constituent of propolis is an effective way of standardization, there might be a 
synergic effect of components within the propolis extract. This effect can be the 
reason that propolis has different pharmacological activities (Banskota, 2001). 
 
 
 Table 1.3 Chemical Composition of Propolis (Sawicka, 2012). 
 
Compounds Percentage 
Fatty and Aliphatic Acids 24-26 % 
Flavonoids 18-20 % 
Sugars 15-18 % 
Aromatic Acids 5-10 % 
Esters 2-6 % 
Vitamins 2-4 % 
Alcohol and Terpens 2-3.3 % 
Microelements 0.5-2 % 
Others 21-27 % 
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1.2.2 Antitumoral Activity of Propolis and Its Active Components 
 
Propolis is a research subject for its antitumoral activity all over the world with local 
extracts since its composition changes with its origin. The common point of the anti-
cancerous effects of propolis is the ability of propolis to trigger apoptosis in cancer 
cells. Some of the active components of propolis as well as alcoholic extractions or 
water-soluble derivatives of propolis were shown to induce apoptosis in cancer cells 
depending on the concentration (Sawicka, 2012). There are many studies conducted 
on propolis or its active components for treatment of cancer which reveals the 
potential of this biological compound in the development of novel anti-cancerous 
agents. 
Numerous studies claim that polyphenols in propolis, activates TRAIL-induced 
apoptosis in cancer cells. Naringenin in lung cancer, Biochanin A in prostate cancer, 
Kaempferol in glioma and chrysin, quercetin, apigenin in various cancer cells were 
particularly identified as a synthesizer of   TRAIL-induced apoptosis (Szliszka, 2013). 
Synthesizing cancer cells to TRAIL-targeted therapies with propolis or its 
polyphenols would increase the anticancer activity of TRAIL so that TRAIL-resistance 
may be overcome by propolis treatment.  
Artepillin C (3,5-diprenyl-4-hydroxycinnamic acid) is one of the active components 
of propolis which causes significant damage to carcinoma and malignant melanoma. 
Intratumor injection of Artepillin C (500g, three times a week) increases the number 
of helper T cells in addition to suppression of tumor growth in mice (Khalil, 2006). 
Caffeic acid phenethyl ester (CAPE) is a strong antioxidant, extracted from propolis 
and it is a well-known NF-κB specific inhibitor (Figure 1-2). It suppresses the cell 
proliferation of some metastatic prostate cancer cell lines as well as sensitizes 
cancer cells to radiation and chemotherapeutic drugs. LNCaP (androgen-sensitive 
human prostate adenocarcinoma cells) xenograft nude mice were orally treated 
with CAPE (10 mg/kg per day for six weeks) and consequently tumor volume was 
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reduced 50% (Liu, 2013). As a result of these findings, it is hypothesized that CAPE 
can be an effective adjuvant therapy for prostate cancer.  
 
Figure 1-2 The Chemical Structure of Caffeic acid phenethyl ester (CAPE) C17H16O4 
(Akyol, 2012). 
 
As a candidate anti-cancer agent, propolis can be a relatively inexpensive solution 
for cancer treatment. Administration of propolis does not lead to side effects on 
rats or humans along with the fact that it can reduce side effects of cancer 
treatment (Watanabe, 2011). A research group from Turkey also supports that 
usage of CAPE prevents the damages and side effects of chemotherapy and 
radiotherapy. They propose the usage of CAPE as a protective agent during 
chemotherapy in clinical trials (Akyol, 2012). A research group from Taiwan claims 
that CAPE has an anti-metastatic and anti-angiogenic effects on cancer cells. Even 
though the exact mechanism of anti-metastatic activity of CAPE is not revealed yet, 
they demonstrated that CAPE has effects on destruction of capillary-like tube 
formation, inhibition of tumor cell invasion, and elimination of VEGF level in vitro 
and in vivo (Liao, 2003). 
Another usage of active components of propolis is as a histone deacetylase inhibitor 
(HDACi). with anticancer activity. Chrysin (Sun, 2012) and NMB-HD-1 (Huang, 2012) 
are examples of HDACis synthesized from propolis. Chrysin, a known potent 
anticancer compound, is a HDAC8 inhibitor as well as it can significantly inhibit 
tumor growth. Chrysin is also important for the standardization of Chinese propolis 
since it is the major index compound (Sun, 2012). NMB-HD-1 has an anti-
proliferative effect and also injection of NMB-HD-1 to MDA-MB-231 breast cancer 
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xenograft model exhibited antitumor activity. This outcome may involve HDAC 
inhibition which changes chromatin core histones so that expression of cell cycle 
regulating genes changes. Another possibility is the suppression of PTEN/AKT 
pathway which inhibits cancer cell growth (Huang, 2012). 
 
1.2.3 Synergistic Effects of Propolis with Other Chemotherapeutic Drugs 
 
Propolis have various functional and biological properties such as antibacterial 
(Grange, 1990)., antimicrobial (Monzote, 2012), anti-oxidative 
(Thirugnanasampandan, 2012), antiviral (Viuda-Martos, 2008), hepatoprotective 
(Albukhari, 2009), anti-cancerious (Sawicka, 2012), anti-ulcerous (Viuda-Martos, 
2008) as well as anti-inflammatory (Banskota, 2001). Especially anti-oxidative and 
anti-inflammatory features of propolis make it a promising candidate as an adjuvant 
to chemotherapy.  
More than 70% of antitumor agents are natural compounds or materials derived 
from natural products (Watanabe, 2011). Propolis is one of the candidates for such 
products while paclitaxel is already one of them. Paclitaxel also known as Taxol® is 
an anticancer agent which was isolated from bark of Taxus brevifolia (Figure 1-3) 
(Khosroushahi, 2011).  
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Figure 1-3 Picture of Taxus brevifolia (Pacific Yew) which Paclitaxel was isolated 
from (McMullen, 2008). 
 
Paclitaxel is widely used for treatment of breast cancer, non-small cell lung cancer, 
ovarian cancer, melanoma, head and neck cancer. Giving paclitaxel in combination 
with propolis, results in maximum protection from induced mammary 
carcinogenesis in rats. Treating breast cancer-bearing rats with 50 mg propolis per 
kg body weight along with 33 mg paclitaxel per kg body weight reduces the toxic 
side effects of paclitaxel by propolis’ immunemodulatory activity. Another effect of 
propolis is free radical scavenging activity against alkoxyl radicals that is due to the 
antioxidant property of propolis. Synergistic action of propolis mixture is distinct 
from the action of a single component since there are diverse effects of propolis on 
cancer treatment (Padmavathi, 2006). 
In another study, ethanolic extract of propolis was used with temozolomide to 
inhibit U87MG (human glioblastoma cell line) cell line growth. Researchers affirmed 
that propolis has cytotoxic effects as well as growth inhibiting activity in 
combination with temozolomide. They think there is at least partial relationship 
between cytotoxic properties and reduced activity of NF-κB since NF-κB is an 
essential survival factor for glioblastomas (Markiewicz-Żukowska, 2013).  
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Caffeic acid phenethyl ester (CAPE), an active component of propolis was found to 
change the characteristics of breast cancer stem cells (bCSCs). CAPE inhibits the self-
renewal and clonal expansion in soft agar, also decrease the CD44 (cell surface 
markers for bCSCs) content and malignancy in bCSCs. Another effect of CAPE is that 
it increases the cycling state of bCSCs so that susceptibility to chemotherapeutic 
agents of bCSCs increases. In conclusion, CAPE can be used effectively for cancer 
treatment in combination with other chemotherapeutic agents (Omene, 2012). 
 
 
 
1.3 Cell Death 
 
Carl Vogt was the first one to describe cell death in 1842 following the 
establishment of cell theory. He observed the elimination of cells and replacement 
of them by new cells (Clarke, 2012). Stress to the cellular system causes cell death 
with a diverse and complex process. Apoptosis, necrosis, autophagy and mitotic cell 
death are the known cell death types for today. An individual cell may have a 
heterogeneous behavior within a population as well as cell death can also be a 
heterogeneous property. Both biochemical and morphological properties may 
cause the heterogeneity in cellular systems (Stevens, 2013). Apoptosis and 
autophagy are the most well-known programmed cell death mechanism however 
there is third one: programmed necrosis. These are the three main forms of 
programmed cell death and they balance survival with cell death for normal cells 
(Ouyang, 2012). 
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1.3.1 Apoptosis 
 
In the case of cellular life, death program comes with the code which gives the life 
itself. In case of emergencies, cells kill themselves for the sake of population of 
other cells. This is also parallel with the evolutionary development since cells cannot 
pass their genetic information if the information is damaged.   
 
 
Figure 1-4 Fas-induced and TNF-induced Apoptosis Models (Nagata, 1997). 
 
If the DNA damage is irreversible, major type of cell death is the apoptosis. 
Apoptosis can be triggered by two different pathways: death receptor (extrinsic) 
and mitochondrial (intrinsic) pathway. When plasma-membrane death receptor, Fas 
binds to its extracellular ligand Fas-L; the extrinsic pathway triggers. Both TNF and 
Fas induces extrinsic pathway of apoptosis (Figure 1-4). Mitochondrial pro-enzymes 
control the intrinsic pathways of apoptosis (Ouyang, 2012). 
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1.3.2 Poly(ADP-ribose) Polymerase-1 (PARP-1) Cleavage 
 
Single and double stranded DNA breaks activate the nuclear protein PARP and PARP 
is also involved in DNA repair, cell cycle regulation, differentiation and 
transformation mechanisms (Whitacre, 1999). PARP binds to DNA single strand 
brakes and induces a structural modification to promote base excision repair. 
Poly(ADP-ribose) (PAR) recruits other DNA damage proteins to the close vicinity and 
PARP induces the synthesis of PAR. Following Poly(ADP-ribosyl)ation (PARylation), 
PARP is needed to be cleaved by cysteinyl-aspartate proteases-3 (caspase-3) 
(Nowsheen, 2012). 
Caspases, calpains, cathepsins, granzymes and matrix metalloproteinases (MMPs) 
are some of the suicidal proteases which cleave PARP from different sites so that 
signature fragments appear (Figure 1-5). Each cleaved fragment has its specific 
molecular weight therefore fragments can be used as a biomarker for specific cell 
death program (Chaitanya, 2010).  
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Figure 1-5 Various Fragments of PARP-1 after cleaved by specific suicidal 
proteases (Chaitanya, 2010). 
 
PARP-1 cleavage by caspases is considered as a hallmark of apoptosis. There are 2 
different possible fragments after the cleavage of PARP by caspases: 85 and 89 kDa 
fragments. These fragments are indicators of apoptosis of the cell. The full-length 
protein is 116 kDa and cleavage by caspase-3 results in 89 kDa fragment. However, 
cleavage by caspases-7 yields two specific fragments, 89 and 24 kDa (Chaitanya, 
2010). Therefore detection of one of these bands shows the association of 
apoptosis. On the other hand, 50 kDa fragment is detected during necrosis 
(Buontempo, 2010). 
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2 Materials 
 
2.1 Propolis Extract 
 
Propolis extracts were kindly provided by Prof. Dr. Orhan Değer from Karadeniz Technical 
University, Faculty of Medicine, Department of Medical Biochemistry. Two different 
batches of DMSO extracts of propolis were used in this study; first batch is 25 mg/ml 
(Propolis-1) and second batch is 100 mg/ml (Propolis-2). Propolis was collected from 
different regions of Turkey by Fanus Gıda Corporation (Trabzon, Turkey) and extractions 
were prepared in laboratories of Karadeniz Technical University with the following method: 
Natural propolis was grinded and mixed until it became powder. For 25 mg/ml propolis 
extract, 0.5 g of propolis powder was mixed with 20 ml DMSO and vortexed. Mixture was 
incubated on the shaker at 150 rpm for 24 hours at 60°C for propolis to dissolve. Mixture 
was filtered with filter paper and the extracts were kept in dark at +4°C. 100 mg/ml propolis 
extract was prepared with the same procedure. 
 
 
2.2 Growth Mediums 
 
Growth mediums of cell lines are given in Table 2.1. 
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Table 2.1 Growth mediums of cell lines 
18 
 
2.3 Buffers and Solutions 
 
Table 2.2 General Solutions 
10% TCA Solution (v/v) 10% TCA in ddH2O 
1% Acetic Acid Solution (v/v) 1% Acetic acid in ddH2O 
0.4% SRB Solution (w/v) 0.4% SRB in 1% Acetic Acid 
10 mM Tris Base Solution 10 mM Tris in ddH2O 
300 ug/ml Hoechst 33258 
Stock Solution 
300 ug/ml Hoechst dissolved in ddH2O (stored in dark) 
1 ug/ml Hoechst 33258 
Working Solution 
1 ug/ml Hoechst diluted from 300 ug/ml Hoechst stock 
solution  dissolved in 1x PBS (kept in dark) 
10x TBS 12.19 g Tris-base and 87.76 g NaCl were dissolved in 1 liter 
of ddH2O and the pH was adjusted to 8 to prepare 10X 
TBS stock solution. 
0.2 % TBS-T 0.2% Tween 20 was added into 1X TBS solution. 
10% APS (w/v) 10% APS in 1% ddH2O 
5 % BSA (w/v) 5% BSA in 0.2 % TBS-T 
5 % milk (w/v) 5% milk powder in 0.2 % TBS-T 
 
Table 2.3 Cell Lysis Buffer 
Reagent Final concentration 
Tris-HCl (pH:8.0) 50 mM 
NaCl 150 mM 
NP-40 1 % 
SDS 0.1 % 
Protease Inhibitor 1x 
ddH2O Rest of the solution 
 
Table 2.4 Bradford Stock Solution 
Coomassie brilliant blue 17.5 mg 
Ethanol 4.75 ml  
Phosphoric acid 10 ml 
final volume with ddH2O= 25 ml 
 
Table 2.5 Bradford Working Solution 
Bradford stock solution 1.5 ml  
95% Ethanol 0.75 ml  
Phosphoric acid 1.5 ml  
final volume with ddH2O= 25 ml 
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Table 2.6 5x Loading Dye 
Tris-HCL, pH:6.8, ,  62.5 mM 
β-mercaptoethanol 5% 
glycerol 15% 
bromophenol blue. 0.001% 
SDS 2% 
 
Table 2.7 30% Acrylamide/Bisacrylamide Solution 
Acrylamide 29 gr 
Bisacrylamide 1 gr 
final volume with ddH2O= 100 ml 
stored in the dark 
 
Table 2.8 SDS Gel Formulation to Prepare two Gels 
Reagents 5% Stacking Gel 10% Resolving Gel 
30% acrylamide/bisacrylamide solution 1.3 ml 6.7 ml 
1.0 M Tris Solution (pH: 8.8) - 7.5 ml 
1.0 M Tris Solution (pH: 6.8) 1.0 ml - 
10% SDS solution 80 ul 200 ul 
10% APS solution 80 ul 200 ul 
TEMED 8 ul 8 ul 
ddH2O 5.6 ml 5.4 ml 
TOTAL= 8 ml 20 ml 
 
 
Table 2.9 5x Running Buffer 
Tris 45 g 
Glycine 216 g 
SDS 15 g 
final volume with ddH2O= 3 liters 
 
 
Table 2.10 Wet Transfer Buffer 
Tris 6 g 
Glycine 28.8g 
Methanol  15% 
final volume with ddH2O= 1 liter 
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Table 2.11 Antibodies and Their Solutions 
Primary Antibodies 
 
PARP-1 (Cell Signaling 46D11): 1:200 in 5% BSA in 0.2 % TBS-T 
 
β-actin (Sigma A5441): 1:5000 in 5% milk powder in 0.2% TBS-T 
 
Secondary Antibodies 
 
Anti-Mouse IgG (Sigma A9044): 1:5000 in 5% milk powder in 0.2% TBS-T 
 
Anti-Rabbit IgG (Sigma A0545): 1:5000 in 5% BSA in 0.2 % TBS-T 
 
 
 
 
Table 2.12 Propidium Iodide (PI) Staining Solution 
Propidium Iodide (PI) stock 50 ug/ml 
RNAse-A 0.1 mg/ml 
Triton X 0.05% 
Dissolved in PBS  
 
 
2.4 General Materials 
 
Table 2.13 Production Information of Materials 
Material Catalog Number Company 
DMEM (Low Glucose) SH30021.01 Hyclone 
Acetic Acid 27225-2.5L-R Sigma Aldrich 
Acrylamide  BP170-500 Fisher Scientific 
Adriamycin (ADRIMISIN 10 
mg) 
L01DB01 Saba İlaç 
APS 420627 Carlo Erba 
Bisacrylamide A3636,0250 AppliChem 
Bovine Pituitary Extract 13028-014 Gibco 
Bromophenol blue. B5525 Sigma Aldrich 
BSA 10 735 078 001 Roche 
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Material Catalog Number Company 
Coomassie brilliant blue 27816 Fluka 
D-Glucose 16325 Riedel de Haen 
DMEM/Ham's F12 F4815 Biochrom 
DMSO A3672,0100 AppliChem 
EGF E9644-2MG Sigma Aldrich 
Ethanol CAS-64-17-5 AlcoMED 
FBS SV30160.03 Hyclone 
Glycerol 346165 Carlo Erba 
Glycine EC200-272-2 Fisher Scientific 
Hoechst 33258 861405 Sigma Aldrich 
Hydrocortisone H0888-19 Sigma Aldrich 
Insulin I1882-100MG Sigma Aldrich 
Isopropanol 1.009.952.500 MERCK 
L-Glutamine K0293 Biochrom 
Methanol 24229-2.5L-R Sigma Aldrich 
Milk powder - Sütaş 
NaCl 1,06404,1000 MERCK 
Nitrocellulose Membrane RPN3032D Amersham 
Nonessential Amino Acids BE13-114E Lonza 
NP-40 NonidetP-40 AppliChem 
Parafilm PM.996 Pechiney 
PBS BE17-516F Lonza 
Penicillin/Streptomycin   SV30010 Hyclone 
Phosphoric acid 4107 Riedel de Haen 
Propidium Iodide (PI) D4864 Sigma Aldrich 
Protease Inhibitor 11873580001 Roche 
RNAse-A EN0531 Thermo Scientific 
RPMI Medium SH30096.01 Hyclone 
SDS L5750 Sigma Aldrich 
Sodium Pyruvate 11360 Gibco 
Sulforhodamine B (SRB) S1402 Sigma Aldrich 
Trichloroacetic Acid (TCA) 33731-100G Sigma Aldrich 
Tris 826 Amresco 
Tris-Base T1503-1KG Sigma Aldrich 
Tris-HCl T-3253 Sigma Aldrich 
Trypsin/EDTA SH30236.01 Hyclone 
Tween 20 0777-1L Amresco 
β-mercaptoethanol M-3148 Sigma Aldrich 
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3 Methods 
 
 
3.1 Cell Culture Techniques 
 
 
3.1.1 Growth Conditions 
 
Every cell line was grown in their appropriate growth medium which is listed in the 
materials section Table 2.1. Cells were passaged when their confluence was over 
70%. Some of the cells were passaged 1:2 while some fast growing cell lines were 
passaged 1:5. When cells reached confluency the growth medium was removed and 
the cells were washed with 1xPBS. 1 ml pre-warmed Trypsin/EDTA was spread into 
75 cm2 flasks and incubated at 37°C for 1-2 minutes. When cells detached from the 
flask surface, trypsin was inactivated with FBS containing fresh culture medium. 
Cells were dispersed by pipetting up and down a few times. Cells were transferred 
to new culture flasks and incubated in a 5% air jacketed CO2 incubator at 37
0C. 
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3.1.2 Cryopreservation of Cells 
 
Cells were incubated 24 h after passaging and 75 cm2 flask full of cells was frozen 
into one tube. Their growth medium was removed and washed with 1x PBS. 1 ml 
Trypsin/EDTA was spread into 75 cm2 flasks and incubated at 37°C for 1-2 minutes. 
When cells appeared to have lost their adherence, trypsin was inactivated by adding 
fresh medium which contains FBS. Cells were transferred into 15 ml tubes and 
centrifuged at 1500 rpm for 5 minutes. Cryopreservative medium was freshly 
prepared by mixing 90% FBS and 10% DMSO. After centrifugation, medium was 
removed and cell pellets were suspended within 1 ml freezing medium. Each cell 
pellet was stored in separate cryotubes at -20°C for 1 hour and -80°C or in liquid 
nitrogen for long term storage. Each vial contains approximately 3-4 millions of 
cells. 
 
3.1.3 Reculturing Frozen Cells 
 
Frozen cells need to be thawed rapidly therefore they were melted down in a water 
bath at 37°C. Melted cells were mixed with 5 ml pre-warmed growth medium and 
centrifuged at 1500 rpm for 5 minutes. After centrifugation, DMSO containing 
freezing medium was removed and cell pellets were suspended within 5 ml fresh 
growth medium and transferred into 25 cm2 flask. Cells were incubated at 37°C with 
5% CO2 air. Next day, the growth medium was removed and the cells were washed 
with 1x PBS. If the cells were confluent enough, the cells were cultured into 75 cm2 
flask as described above. Cells were incubated at 37°C with 5% CO2 air. The cells 
were passaged at least once before using for further manipulations. 
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3.1.4 Storing Cell Pellets for Protein Isolation 
 
The cells pellets were collected for protein extraction to use for Western blot 
experiments. The drug treated and un-treated cells were cultured in 6 well plates. 
Since apoptotic cells detach from the plate surface and remain in the growth media, 
growth medium in each well was collected into separate 15 ml tubes. The wells 
were washed with 1x PBS and PBS was added into same 15 ml tubes detached cells 
containing growth medium.  0.3 ml Trypsin/EDTA was spread into each well of 6 
well plate to detach the adherent cells and incubated at 37°C for 1-2 minutes. When 
cells appeared to have lost their adherence, trypsin was inactivated by adding fresh 
medium which contains FBS. Cells were transferred into appropriate tubes 
containing the cells collected from the previous steps and centrifuged at 1500 rpm 
for 5 minutes at +4°C. The supernatant was removed and the cell pellets were 
resuspended with ice-cold 1x PBS. Tubes were centrifuged at 1500 rpm for 5 
minutes at +4°C. PBS was removed and tubes were soaked in liquid nitrogen 
immediately to freeze them. Pellets were stored at -80°C for further experiments.  
 
3.1.5 Cell Counting with Haemocytometer 
 
Haemocytometer was used to determine the number of cells in the cell cultures. 
Certain number of cells was required for IC50 calculations, xCELLigence and other 
propolis treatment experiments. The cultured cells were trypsinized and 
resuspended in culture mediums as described above. Haemocytometer was cleaned 
with 70% ethanol and a coverslip was gently put onto the chamber area. The cell 
suspension was mixed gently to ensure equal distribution of the cells in the tube 
and then 10 ul of cell suspension was taken and placed into the edge of the 
chambers. Two chambers were used for counting. The cells in 16 corner squares 
were counted under the light microscope for both chambers of Haemocytometer. 
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Average of those numbers was multiplied with 104. This gives the approximate cell 
number within 1 ml of cellular solution. The certain amount of cells for each cell line 
was used for various experiments.  
 
 
3.2 Sulforhodamine B (SRB) Assay 
 
Different cell lines were plated (Table 3.1) into the 96 well plates and treated with 
Propolis-24 hours later. At a given amount of time later, cells need to be fixed to 
stop further cell growth. After fixation cells were stained with SRB and the color 
intensity was measured with ELISA reader. Resulting optical density (OD) is 
correlated with the amount of cells. 
 
Table 3.1 Starting cell number for IC50 calculations 
  Propolis-1 Propolis-2 
BT-20 12,000 12,000 
BT-474 20,000 10,000 
CAMA-1 4,000 4,000 
HCC-1937 10,000 8,000 
hTERT-HME1 6,000 6,000 
MCF10A 4,000 5,000 
MCF12A 5,000 6,000 
MCF7 3,000 3,000 
MDA-MB 231 4,000 7,000 
MDA-MB-157 10,000 10,000 
MDA-MB-361 20,000 20,000 
MDA-MB-453 4,000 8,000 
MDA-MB-468 4,000 4,000 
T47D 5,000 4,000 
ZR-75-1 5,000 6,000 
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3.2.1 Trichloroacetic acid (TCA) Fixation 
 
For propolis and DMSO control treated cells, fixation was done as following method 
for each well. These cells were plated and after 24 h, treated with either propolis or 
DMSO. Cells need to be fixed after 72 h incubation of treatment. This part was done 
by using multi-channel pipetting for 96 well plate.  
 Remove growth medium with pipet 
 Add 100-200 ul PBS at room temperature and shake gently (Add 500 ul for 
24 well plates) 
 Remove PBS with pipet 
 Add 50 ul ice-cold 10% TCA solution (Add 200 ul for 24 well plates) 
 Incubate at +4°C for 1 hour 
 Wash with excess ddH2O for 5 times 
 Leave at room temperature for air dry 
 
 
3.2.2  Sulforhodamine B (SRB) Staining 
 
TCA fixed and air-dried plates were stained with SRB dye solution for further 
measurements as in the following method: 
 0.4% SRB prepared with 1% acetic acid solution 
 Add 50 ul SRB solution to each well and make sure that solution covers all 
the bottom surface of each well (Add 200 ul for 24 well plates) 
 Incubate the dye at room temperature for 10 minutes in dark.   
 Wash with excess 1% acetic acid solution 5 times 
 Leave at room temperature for air dry 
 Add ice-cold 100 ul 10mM Tris-base solution (Add 500 ul for 24 well plates) 
 Solubilize the dye in the Tris-base solution on the shaker for 5 minutes 
 Read the results with ELISA reader at 515 nm 
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3.3 IC50 Calculations 
 
For the IC50 calculations SRB assay results were used. Cells were treated with 
propolis and DMSO control with serial diluted concentrations of propolis for at least 
5 different concentrations. Samples were collected and calculated at least in 
triplicates. OD results were then converted to the percent cell death values by using 
following formula. At a given concentration: 
percent cell death = (1 – average OD propolis/average OD DMSO)*100 
 
Percent cell death values of each concentration were calculated and drawn on an X-
Y Scatter graph on Excel sheet. For this graph logarithmic trend line was added and 
50% inhibition intersection was calculated with given formula on Excel: 
IC50 value =EXP((50 – y-intersection point of trend line)/ slope of trend line) 
 
This formula gives IC50 value of propolis at a given time point for particular cell line. 
Also coefficient of determination was checked to see the significance of calculated 
IC50 value. That was calculated by Excel by R
2 value of the trend line. For this study 
IC50 values were calculated only if the R
2 values are in between 0.75 -1.00.  
 
3.4 Statistical Analyses 
 
Standard Error of the Mean (SEM) 
To determine the standard deviation between triplicate or quadruplicate samples, 
SEM analysis was performed. STDEVA function was used for the calculation of 
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standard deviation and the result was divided by square root of sample number. 
The result shows the standard error of the mean (SEM) for selected samples. 
SEM = STDEVA (Sample1, sample2,…) / (√ sample number) 
 
Student’s t-test 
To calculate the significance of two groups such as luminal-basal, ER positive-
negative, etc. T-TEST function was used with Microsoft Excel. Function was used to 
compare the significance of two subgroups with two-tailed distribution and two-
sample unequal variance. P<0.05 were analyzed as significant result.  
 
 
3.5 Live Cell Proliferation Assay (xCELLigence) 
 
 
The xCELLigence is a system that monitors dynamic cellular events in real time and 
gives quantitative information about biological status of the cells including cell 
number and viability. This system enabled to provide good sensitivity and 
reproducibility in monitoring an entire cell population in a culture well. The 
technology behind this system comes from the design of the platform. E-plate 96 is 
similar to 96 well plates but it contains electrode sensors integrated into the each 
well so that each well can be monitored separately. The electrode impedance (Z) 
increases as the number of cells increase on it (Figure 3-1).  
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Figure 3-1 Schematic Drawing of the Working Principle of xCELLigence (ACEA 
Bioscience Inc.) 
 
Before inoculating the cells to the E-plate 96, 50 ul of growth medium was put into 
E-plate 96 wells for each cell line to obtain background readings (takes only 1 
minute). This step also allows us to determine if there are any inconvenient wells 
exist in that particular plate so that a problematic well can be omitted from the 
experiment design and replaced with another well. The certain number of cells 
were from cell suspensions were added on top of growth mediums with 100 ul/well 
volume where the total volume will be 150 ul/well in total. The xCELLigence system 
(RTCA SP Station) where the cells were replaced was kept at 37°C with 5% CO2 air 
incubator during the experiment.  Depending of the cell growth (between 24 to 72 
hours), cells were treated with either DMSO or Propolis-2 with pre-determined 
concentrations. The treatment time point determined as the cells pass 0.75 Cell 
Index and before they reach to 1.25 Cell Index so that cells can be treated when 
they are in the log phase. At the beginning of the experiment, Cell Index values 
were recorded for every 30 minutes but after the drug treatment the Cell Index 
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values were recorded for every 10 minutes to observe the fast drug response.  After 
the observation of fast drug response the counter changed into record Cell Index for 
every 30 minutes. Long-term drug response was recorded at least 72 hours after the 
drug treatment. 
 
3.6 Nuclear Staining with Hoechst 33258 
 
Cells (80,000 cells/well) were plated in cover slips in 6 well plates and after 24 h 
cells were treated with 0.1 % DMSO control or 100 ug/ml Propolis-2. Cells were 
incubated at 37°C with 5% CO2 air. After 48 h incubation, growth medium was 
removed and cells were washed with 1x PBS. After removal of PBS, cells were fixed 
with 1 ml ice-cold 100% methanol and kept for 10 minutes at +4°C. Cells were 
washed with ice-cold 1x PBS. 1 ug/ml Hoechst 33258 solution was prepared with 
ice-cold 1x PBS. After removal of PBS, cells were stained with 400 ul Hoechst 
solution and incubated at room temperature for 5 minutes in the dark. Then the 
cells were destained with ddH2O for 10 minutes at room temperature in the dark. 
Water was removed and cover slips were mounted on glass slides with glycerol. 
Cover slips were fixed onto the slides by wiping transparent nail polish to the edges. 
The stained cells’ nuclear morphology was examined under fluorescent microscope.  
 
3.7 Western Blot 
 
3.7.1 Cell Lysis 
 
Cell pellets were taken from -80°C freezer and thawed on ice. Each pellet was 
resuspended with 50 ul (depending on to cell pellet size) cell lysis buffer, vortexed 3 
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times and left on ice for 30 minutes with occasional vortexing. Samples were 
centrifuged at 13000 rpm at +4°C for 15 minutes. The supernatant was taken into 
the fresh tubes. Protein samples were always stored in -80°C and kept on ice during 
the experiments.   
  
3.7.2 Bradford Assay for Protein Quantitation and Sample Preparation 
 
Bradford assay was used to determine the amount of protein in each cell lysate. 
BSA Standard Curve was prepared before using Bradford working solution. BSA 
samples were prepared in Cuvettes as in Table 3.2. Samples were measured with 
spectrophotometer at 515 nm wavelength and absorbance results were used to 
draw a BSA Standard Curve (Figure 3-2). Trendline of this curve was used for protein 
quantitation of samples. 
 
Table 3.2 Sample Preparation for BSA Standard Curve 
Vial # Blank 1 2 3 4 5 6 
BSA (ug/ml) - 1 2 4 8 16 32 
ddH2O (ul) 100 99 98 96 92 84 68 
Bradford (ul) 900 900 900 900 900 900 900 
TOTAL (ul) 1000 1000 1000 1000 1000 1000 1000 
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Figure 3-2 BSA Standard Curve 
 
After generating the BSA Standard Curve, protein samples were prepared as in 
Table 3.3 to measure with spectrophotometer at 515 nm wave length. The 
measurements were taken and the results were calculated with the trendline 
equation of BSA Standard Curve (y=0.2021x-0.2554). Since 2 ul of samples were 
loaded to the cuvettes, the results were divided by 2. Absorbance of samples and 
their protein concentrations were calculated and given in Table 3.4.  
 
Table 3.3 Sample Preparation for Protein Quantitation with Spectrophotometer 
Vial # Blank Samples 
Cell Lysis Buffer (ul) 2 - 
Protein Sample (ul) - 2 
ddH2O (ul) 98 98 
Bradford (ul) 900 900 
TOTAL (ul) 1000 1000 
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Table 3.4 Absorbance and Protein Concentrations of Samples for Western Blot 
Analysis. 
Sample Name Absorbance 
Protein 
Conc. 
(ug/ul) 
for 50 
ug (ul) 
ddH2O 
(ul) 
5X 
Loading 
dye (ul) 
MCF10A 
DMSO(%0.1) 0,7606 22,99 2,18 9,82 3 
Propolis(100ug/ml) 0,4599 16,18 3,09 8,91 3 
MDA-MB-231 
DMSO(%0.1) 0,5867 19,05 2,62 9,38 3 
Propolis(100ug/ml) 0,4558 16,09 3,11 8,89 3 
T47D 
DMSO(%0.1) 0,4038 14,91 3,35 8,65 3 
Propolis(100ug/ml) 0,2771 12,05 4,15 7,85 3 
CAMA-1 
DMSO(%0.1) 0,4285 15,47 3,23 8,77 3 
Propolis(100ug/ml) 0,1991 10,28 4,86 7,14 3 
BT-20 
DMSO(%0.1) 0,8366 24,71 2,02 9,98 3 
Propolis(100ug/ml) 0,353 13,76 3,63 8,37 3 
BT-474 
DMSO(%0.1) 0,3074 12,73 3,93 8,07 3 
Propolis(100ug/ml) 0,0323 6,51 7,68 4,32 3 
MDA-MB-231 
DMSO(%0.1) 0,5058 17,22 2,90 9,10 3 
IC50(74 ug/ml) 0,0082 5,96 8,38 3,62 3 
Propolis(100 ug/ml) 0,2985 12,53 3,99 8,01 3 
IC100(148 ug/ml) -0,0519 4,60 10,86 1,14 3 
MDA-MB-231  
(Positive 
Control)  
Adriamycin 500 
ng/ml 0,2178 10,71 4,67 7,33 3 
Adriamycin 750 
ng/ml 0,3035 12,64 3,95 8,05 3 
Adriamycin 1000 
ng/ml 0,1351 8,83 5,66 6,34 3 
MCF10A 
Untreated Cell Lines 
0,1726 9,68 5,16 6,84 3 
T47D 0,0819 7,63 6,55 5,45 3 
CAMA-1 0,038 6,64 7,53 4,47 3 
BT-20 -0,0734 4,12 12,14 -0,14 3 
BT-474 0,0431 6,75 7,40 4,60 3 
MDA-MB-231 0,2143 10,63 4,71 7,29 3 
BSA curve is y=0.2021x-0.2554 TOTAL 15 ul 
 
 
Western blot analysis was performed with these protein extracts. 50 mg of protein 
was mixed with 1x loading dye and added up to final volume of 15 ul with ddH2O 
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(Table 3.4). Samples were incubated on boiling water for 5 minutes. After a quick 
spin down, samples were ready to load into SDS gel. The samples were always kept 
on ice during the experiments. 
 
3.7.3 Preparation of SDS gel and Its Transfer to Nitrocellulose Membrane 
 
The material used for gel preparation was pre-washed with soap, rinsed with tap 
water and then with distilled water to get rid of the debris on the material. The 
apparatus was set and 10% resolving gel was prepared and poured in between the 
glasses and then filled with isopropanol.  After polymerization of resolving gel, 
isopropanol was removed and the empty area was washed with distilled water to 
remove remaining alcohol. 5% stacking gel was prepared, poured on top of 
resolving gel and combs were placed in between glasses. After polymerization of 
gels, glasses with gels were placed in the tank that was filled with 1x running buffer. 
Combs were carefully removed and the wells were cleared with a syringe. The first 
well was loaded with 5 ul of PageRuler Plus Prestained Protein Ladder (Thermo 
Scientific) and samples were loaded into the wells. Power supply was adjusted to 90 
Volts until proteins passed through the stacking gel and then increased to 120 Volts. 
The gels were transferred to nitrocellulose membrane with wet transfer method. 
Wet transfer buffer was prepared with 15% methanol concentration. Whatman 
papers, sponges and membranes were soaked in wet transfer buffer for a few 
minutes. From negative plate towards positive plate; sponge, two Whatman papers, 
gel, nitrocellulose membrane, two Whatman papers, and sponge were aligned one 
top of each other. Before putting the last sponge, air bubbles were destroyed by 
rolling a tube on the layers. Transfer cassettes were placed in tank and filled with 
wet transfer buffer. Power supply was adjusted to 80 Volts and the gels were run 
for approximately 2 hours. 
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3.7.4 Blocking & Antibody Incubations 
 
Blocking solution was prepared with 5% BSA in 0.2 % TBS-T. Each membrane was 
placed in an appropriate container and the container was filled with blocking 
solution. Membranes were incubated for 1 hour on shaker (very slow) at room 
temperature. At the end, membranes were prepared for antibody incubation: Each 
membrane was cut from the 55 kDa and 35 kDa marker band for different primary 
antibodies. (Figure 3-3: The protein loading marker and the gel configuration where 
the dashed lines show the cutting sites of the gels.  )  
 
 
Figure 3-3: The protein loading marker and the gel configuration where the 
dashed lines show the cutting sites of the gels.   
 
After blocking, membranes were placed in an appropriate container and containers 
were filled with its primary antibody (Table 2.11 and Figure 3-3). They were 
incubated with constant shaking (very slow) at +4°C over-night. After incubation, 
membranes were washed with 0.2 % TBS-T for 10 minutes on shaker (fast) at room-
temperature, 3 times. Then, secondary antibody (Table 2.11 and Figure 3-3) 
incubation was done, on shaker (very slow) at room temperature for 2 hours. After 
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incubation, membranes were washed three times with 0.2 % TBS-T for 10 minutes 
on shaker (fast) at room-temperature.  
Clarity™ Western ECL Substrate (Bio-Rad) material was used for detecting the signal 
of secondary antibodies. The membranes were placed on a 10x10 cm parafilm on 
the bench. Each membrane was coved with 250-350 ul (according to area of the 
membrane) 1:1 mixed ECL solution drop by drop. Membranes were incubated for 5 
minutes at room-temperature and plastic covers were put on top of every 
membrane so that solution was not exposed to light.  After incubation membranes 
were placed on glass plate. The x-ray film was used to capture image of the 
membranes in the dark room. Membranes were exposed to film between 1-5 
seconds depending of the intensity of the bands. 
 
3.7.5 ImageJ Analysis 
 
Resulting bands on film were analyzed with ImageJ software (National Institutes of 
Health (NIH)) which is a public domain Java image processing program. The resulted 
band intensities need to be quantified to be able to compare the western blot 
results. Films were scanned and saved as jpeg photo. These photos were used for 
ImageJ analysis. The bands were selected with a rectangular shape option of the 
program and all the lanes were repeated with the same rectangular selection. At 
the end rectangular area was plotted by the program and the resulting band 
intensity was quantified. The comparable data was calculated by dividing PARP-1 
protein intensity to its β-actin loading control. The resulting values were displayed 
in bar graphs. 
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3.8 FACS 
 
3.8.1 Cell Fixation 
 
Propolis-treated and un-treated cells were used for staining with Propidium iodide 
(PI) to analyze the cell cycle stages with FACS method. Six well plates were used for 
culturing the cells and for treatment. Since apoptotic cells detach from the plate 
surface and remain in the growth media, each well was transferred into separate 15 
ml tubes and labeled. Then, each well was washed with 1x PBS and PBS was 
collected into same tubes containing the detached cells. 0.3 ml Trypsin/EDTA was 
put into each well of 6 well plate and incubated at 37°C for 1-2 minutes to detach 
the adherent cells. When the cells appeared to have lost their adherence, trypsin 
was inactivated by adding fresh medium which contains FBS. Cells were transferred 
into appropriate tubes containing the cells collected in previous steps and 
centrifuged at 1500 rpm for 5 minutes at +4°C. Supernatant was removed and cell 
pellets were resuspended by gentle pipetting with 1 ml 1x PBS. Cell suspensions 
were vortexed vigorously and 2.5 ml of ice-cold 100% absolute ethanol was added 
drop wise to prevent cell clumps during fixation. Cell suspensions were incubated 
for 30 minutes on ice with occasional vortexing. Fixed cell suspensions were stored 
at +4°C overnight before the PI staining procedure. 
 
3.8.2 Cell Staining with Propidium iodide (PI) 
 
Fixed cell suspensions were centrifuged at 1500 rpm for 5 minutes at +4°C. The 
supernatant was aspirated. Cells were stained with 500 ul PI Staining Solution and 
suspensions were pipetted gently to break cell clumps. Since PI is light-sensitive, 
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tubes need to be kept in dark after this step. Cells were incubated at 37°C for 40 
minutes with occasional vortexing. After incubation, 3 ml 1x PBS was added onto 
each tube and tubes were centrifuged at 1500 rpm for 5 minutes at +4°C. The 
supernatant was removed and cell pellets were resuspended in 200-500 ul 1x PBS 
(according to size of the pellet). Cell suspensions were transferred into special tubes 
to analyze them in Flow Cytometer. 
 
 
3.9 Scratch Assay 
 
The in vitro scratch assay (wound healing assay) is an easy, low-cost and well-
developed method to measure cell invasion in vitro.  A straight line of cells are 
scraped from the plate and the invasion of the cells through this scraped line is 
observed via light microscope. 
FBS concentration in the growth medium was dropped from 10 % to 0.1 % to 
prevent cells growing through the scratch. By this way, wound healing assay can 
display the invasion properties of cells but not the proliferation. There were 6 
conditions for this set up to observe the invasion rate: 
 10 % FBS containing growth medium treated cells (untreated, mock cells) to 
observe the effect of proliferation and compare it with 0.1 %  FBS medium 
treated cells, 
 0.1 % FBS containing growth medium treated cells to observe the effect of 
decreased FBS and compare it with DMSO control cells, 
 0.1 % FBS + 0.1 % DMSO containing growth medium treated cells as a 
control for propolis treated cells, 
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 0.1 % FBS + 50, 75 (IC50 value propolis for MDA-MB-231 cells) and 100 
ug/ml Propolis-2 containing growth medium treated cells to see the effect of 
gradually increasing concentrations of propolis on cell invasion ability. 
 
Cells (500,000 cells/well) were seeded in 6 well plate to obtain high confluency and 
24 hours later, scratches were made with a 200 ul micropipette tip. Cells were 
washed with 1X PBS twice to get rid of cell debris in the medium and then cells 
were treated with the growth mediums listed above. Right after the scratches were 
performed, time zero photos were taken to observe the scratches borders clearly. 
Then, the photos were taken at 6, 12, 24, 36 and 48 h intervals under the light 
microscope with 10X magnification. 
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4 RESULTS 
 
 
4.1 Analysis of Propolis' Effects in Cancer Cells 
 
Two different propolis extracts were used in this study to analyze its cytotoxic 
effects on cancer cells by using SRB staining and ELISA reading. First propolis extract 
received from Karadeniz Technical University (Propolis-1) was prepared in DMSO 
and the stock at a concentration of 25 mg/ml. The initial studies were performed 
with increasing concentrations (starting from 100 ng/ml up to 2000 ng/ml) of 
propolis by using FOCUS cell line at two different time points (48 and 72 h). The 
ELISA reading as a result of SRB staining was given at Table 4.1 and results of these 
experiments were analyzed in Figure 4-1. 
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Table 4.1: The ELISA reading results that show the cytotoxic effects of Propolis-1 
and DMSO on FOCUS cells (A, 48h; B, 72h incubations). 
A)  
FOCUS 48h 
3000 
cells/well 
Concentration 
(ng/ml) 
Set 1 Set 2 Set 3 Average SEM 
DMSO 
100 0.011 0.026 0.012 0.016 0.005 
250 0.005 0.023 0.046 0.025 0.012 
500 0.004 0.01 0.012 0.009 0.002 
750 0.033 0.03 0.029 0.031 0.001 
1000 0.005 0.007 0.013 0.008 0.002 
2000 -0.003 0 -0.003 -0.002 0.001 
Propolis 
100 0.046 0.051 0.027 0.041 0.007 
250 0.018 0.027 0.011 0.019 0.005 
500 0.013 0.019 0.015 0.016 0.002 
750 0.019 0.015 0.003 0.012 0.005 
1000 0.011 -0.007 0.001 0.002 0.005 
2000 0.008 -0.001 0.001 0.003 0.003 
 
B)  
 
      FOCUS 72h 
3000 
cells/well 
Concentration 
(ng/ml) 
Set 1 Set 2 Set 3 Average SEM 
DMSO 
100 0.037 0.032 0.157 0.075 0.041 
250 0.136 0.178 0.091 0.135 0.025 
500 0.012 0.029 0.026 0.022 0.005 
750 0.048 0.052 0.033 0.044 0.006 
1000 0.024 0.057 0.036 0.039 0.01 
2000 0.017 0.015 0.023 0.018 0.002 
Propolis 
100 0.108 0.126 0.084 0.106 0.012 
250 0.038 0.02 0.078 0.045 0.017 
500 0.023 0.01 0.025 0.019 0.005 
750 0.018 0.008 0.09 0.039 0.026 
1000 0.029 0.019 0.021 0.023 0.003 
2000 0.031 0.001 0.037 0.023 0.011 
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Figure 4-1: The cell proliferation rate of FOCUS cells after propolis treatment.  The 
cells were treated with Propolis-1 and DMSO at 48 h (A) and 72 h (B). Standard 
error of the mean (SEM) for each calculation is given at Table 4.1. (*, p<0.1; **, 
p<0.05) 
 
These analyses showed that the Propolis-1 at low concentrations (100 ng/ml up to 
2000 ng/ml) did not result with a significant cytotoxic effect. Therefore, the 
concentration of Propolis-1 was increased to 50 ug/ml. The cell proliferation rate 
A 
B 
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was measured at different time points (24, 48 and 72 h) by using FOCUS and Huh7 
hepatocellular carcinoma cell lines. The ELISA reading as a result of SRB staining was 
given at Table 4.2 and the results of these experiments were analyzed in Figure 4-2.  
 
Table 4.2: The ELISA reading results that show the cytotoxic effects of Propolis-1 
and DMSO on FOCUS (A) and Huh7 (B) cells at different time points (24 h, 48 h, 
and 72 h). The starting cell number was 20,000 cells/well into 24 well plates. 
A)  
FOCUS Time Set 1 Set 2 Set 3 Set 4 Set 5 Set 6 Average SEM 
Mock 
24h 0.094 0.097 0.085 0.105 0.098 0.108 0.098 0.003 
48h 0.216 0.221 0.212 0.24 0.217 0.214 0.22 0.004 
72h 0.338 0.43 0.383 0.392 0.382 0.31 0.373 0.017 
DMSO 
24h 0.084 0.088 0.094 0.096 0.091 0.09 0.091 0.002 
48h 0.214 0.243 0.229 0.224 0.266 0.248 0.237 0.008 
72h 0.125 0.116 0.147 0.102 0.104 0.093 0.115 0.008 
Propolis-1 
50 ug/ml 
24h 0.069 0.067 0.068 0.078 0.062 0.064 0.068 0.002 
48h 0.109 0.096 0.078 0.091 0.097 0.082 0.092 0.005 
72h 0.038 0.03 0.026 0.016 0.018 0.016 0.024 0.004 
 
B)  
 
         Huh7 Time Set 1 Set 2 Set 3 Set 4 Set 5 Set 6 Average SEM 
Mock 
24h 0.064 0.062 0.069 0.073 0.07 0.064 0.067 0.002 
48h 0.136 0.138 0.134 0.139 0.154 0.148 0.142 0.003 
72h 0.289 0.295 0.3 0.306 0.309 0.264 0.294 0.007 
DMSO 
24h 0.065 0.057 0.057 0.053 0.059 0.056 0.058 0.002 
48h 0.118 0.13 0.128 0.143 0.136 0.143 0.133 0.004 
72h 0.324 0.3 0.266 0.293 0.32 0.307 0.302 0.009 
Propolis-1 
50 ug/ml 
24h 0.043 0.043 0.038 0.042 0.039 0.043 0.041 0.001 
48h 0.067 0.075 0.063 0.064 0.076 0.078 0.071 0.003 
72h 0.083 0.063 0.087 0.083 0.084 0.084 0.081 0.004 
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Figure 4-2: The cell proliferation rate of FOCUS (A) and Huh7 (B) cells after 
treatment with Propolis-1 and DMSO at 24 h, 48 h, and 72 h time points. Standard 
error of the mean (SEM) for each calculations were given at Table 4.2. (**, p<0.05) 
 
 
As a result of the above analysis, the most significant time point on HCC cell lines 
showing significant cytotoxic effect was observed at 72 h with 50 ug/ml of Propolis-
1. Then the following experiments were designed to analyze the time points and 
A 
B 
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different concentration of Propolis-1 (25, 50 and 75 ug/ml) on five different cell 
lines (FOCUS and Huh7 are hepatocellular carcinoma cells; SK-LC is a lung cancer cell 
line; MDA-MB-231 is breast carcinoma cell line) and non-tumorigenic breast cell line 
(MCF12A). For each cell line 20000 cells/well were plated on 24 well plates and 
experiments were designed as triplicates. The cells were treated with indicated 
concentrations of Propolis-1 and DMSO after 24 h incubation. The cells were fixed 
and cell numbers were counted with SRB staining method at 72 h time point after 
24 h treatment. The ELISA reading as a result of SRB staining was given at Table 4.3 
and the results of these experiments were analyzed in Figure 4-3. 
 
 
Table 4.3: The ELISA reading results of Propolis-1 and DMSO on FOCUS, Huh7, SK-
LC, MDA-MB-231 and MCF12A cell lines. 
FOCUS  (20000 cells/well) Set 1 Set 2 Set 3 Average SEM 
25ug/ml DMSO 0.857 0.752 0.003 0.537 0.269 
25ug/ml Propolis 0.306 0.402 0.415 0.374 0.034 
50ug/ml DMSO 0.642 0.942 0.043 0.542 0.264 
50ug/ml Propolis 0.042 0.095 0.119 0.085 0.023 
75ug/ml DMSO 0.246 0.312 0.211 0.256 0.03 
75ug/ml Propolis 0.005 0.007 0.008 0.007 0.001 
Huh7  (20000 cells/well) Set 1 Set 2 Set 3 Average SEM 
25ug/ml DMSO 0.431 0.616 0.019 0.355 0.176 
25ug/ml Propolis 0.072 0.141 0.128 0.114 0.021 
50ug/ml DMSO 0.331 0.535 0.177 0.348 0.104 
50ug/ml Propolis 0.025 0.043 0.07 0.046 0.013 
75ug/ml DMSO 0.279 0.387 0.13 0.265 0.075 
75ug/ml Propolis 0.004 0.013 0.011 0.009 0.003 
SK-LC  (20000 cells/well) Set 1 Set 2 Set 3 Average SEM 
25ug/ml DMSO 0.219 0.287 0.002 0.169 0.086 
25ug/ml Propolis 0.035 0.042 0.051 0.043 0.005 
50ug/ml DMSO 0.144 0.247 0.025 0.139 0.064 
50ug/ml Propolis 0.038 0.035 0.034 0.036 0.001 
75ug/ml DMSO 0.108 0.162 0.111 0.127 0.018 
75ug/ml Propolis 0.002 0.004 0.002 0.003 0.001 
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MDA-MB-231 (20000 
cells/well) 
Set 1 Set 2 Set 3 
Average SEM 
25ug/ml DMSO 0.122 0.101 0.093 0.105 0.009 
25ug/ml Propolis 0.057 0.064 0.061 0.061 0.002 
50ug/ml DMSO 0.126 0.09 0.097 0.104 0.011 
50ug/ml Propolis 0.049 0.043 0.043 0.045 0.002 
75ug/ml DMSO 0.074 0.118 0.116 0.103 0.014 
75ug/ml Propolis 0.012 0.01 0.007 0.01 0.001 
MCF12A (20000 cells/well) Set 1 Set 2 Set 3 Average SEM 
25ug/ml DMSO 0.052 0.075 0.052 0.06 0.008 
25ug/ml Propolis 0.043 0.038 0.044 0.042 0.002 
50ug/ml DMSO 0.041 0.066 0.088 0.065 0.014 
50ug/ml Propolis 0.031 0.033 0.037 0.034 0.002 
75ug/ml DMSO 0.041 0.057 0.013 0.037 0.013 
75ug/ml Propolis 0.003 0.005 0.004 0.004 0.001 
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Figure 4-3: Cell proliferation of FOCUS (A), Huh7 (B), SK-LC (C), MDA-MB-231 (D) 
and MCF12A (E) cell lines with increasing concentrations of Propolis-1 and DMSO. 
Values are the average of at least three independent data sets. Error bars represent 
standard error of the mean of triplicates given at Table 4.3. (*, p<0.1; **, p<0.05) 
 
According to above analysis, higher concentrations of propolis have a greater effect 
on cell number decrease in each cell line. When the ratio of DMSO over propolis 
was calculated (Table 4.4), the effect of propolis was revealed more clearly (Figure 
4-4). As the concentration of propolis increases, decrease in the cell number 
became up to 10 fold more than low concentrations of propolis. 
 
Table 4.4: Comparison of control DMSO and propolis treated cells proliferation 
ratio. Each cell lines fold decrease ratio was calculated by dividing control DMSO 
cell number to propolis value (data was taken from Figure 4-3). 
Fold 
Decrease 
FOCUS Huh7 SK-LC MDA-MB-231 MCF12A 
25 ug/ml   1,4 3,1 3,9 1,7 1,4 
50 ug/ml   6,4 7,6 3,9 2,3 1,9 
75 ug/ml   36,6 29,4 42,3 10,3 9,3 
E 
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Figure 4-4: The relative fold change of each propolis treated cell line at different 
concentrations of Propolis-1. Each cell lines fold decrease ratio was calculated by 
dividing control DMSO value to propolis value (data was taken from Table 4.3). 
 
 
4.2 IC50 Values for Propolis extracts for Breast Carcinoma Cell 
Lines 
 
IC50 value determination was started with inoculation of breast carcinoma cells into 
96 well plates. The numbers of cells were different for each cell line and indicated in 
the related sections. 24 hours later, cells were treated with serial dilutions of 
propolis and control DMSO. Propolis extract dissolved in DMSO, therefore the same 
volume of DMSO was used in serial dilutions as controls. Cells were fixed with TCA 
to 72 hours after the treatment. Cells were stained with SRB and the color intensity 
was measured with ELISA reader. Resulting optical density (OD515) is correlated with 
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the amount of cells. Samples were collected and calculated at least in triplicates and 
standard error of mean (SEM) was calculated according to sample number. IC50 
values were analyzed with at least 5 different concentrations of propolis. All the IC50 
value calculations were analyzed the same way. Two different batches of DMSO 
extracts of propolis were used in this study; first batch is 25 mg/ml (Propolis-1) and 
second batch is 100 mg/ml (Propolis-2). Propolis was collected from different 
regions of Turkey by Fanus Gıda Corporation (Trabzon, Turkey) and extractions were 
prepared in laboratories of Karadeniz Technical University, Medical biochemistry 
laboratories, Trabzon. 
 
IC50 Values of Propolis Extracts for Non-Tumorigenic Cell Lines (MCF10A and 
MCF12A) 
Analysis of IC50 value of propolis extracts on MCF10A was performed with following 
conditions: 
Propolis-1: 100-50-25-12.5-6 ug/ml, 4000 cells were used in each well. MCF10A cell 
line’s IC50 value was calculated as 45 ug/ml (Figure 4-5, A). The experiment was 
performed in triplicate. 
Propolis-2: 200-150-100-75-37.5 ug/ml, 5000 cells were used in each well. MCF10A 
cell line’s IC50 value was calculated as 72 ug/ml (Figure 4-5, B). The experiment was 
performed in triplicate. 
The original data for ELISA reading results are given in Appendix Table 8.1 for 
Propolis-1 and Appendix Table 8.2 for Propolis-2. 
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Figure 4-5: Calculation of IC50 values for propolis extracts in MCF10A cells. Each 
point shows the percent cell death at different concentrations of Propolis extracts. 
A, The IC50 value for Propolis-1 is 45 ug/ml and R
2 value is R2=0.7781. B, The IC50 
value for Propolis-2 is 72 ug/ml and R2 value is R2=0.8955. Error bars represent 
standard error of the mean (SEM). 
 
 
A 
B 
52 
 
Analysis of IC50 value of propolis extracts on MCF12A was performed with following 
conditions: 
Propolis-1: 100-80-50-40-25-12.5 ug/ml, 5000 cells were used in each well. MCF12A 
cell line’s IC50 value was calculated as 35 ug/ml (Figure 4-6, A). The experiment was 
performed in triplicate. 
Propolis-2: 200-150-100-75-50-37.5 ug/ml, 6000 cells were used in each well. 
MCF12A cell line’s IC50 value was calculated as 45 ug/ml (Figure 4-6, B). The 
experiment was performed in quadruplicate. 
The original data for ELISA reading results are given in Appendix Table 8.3 for 
Propolis-1 and Appendix Table 8.4 for Propolis-2. 
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Figure 4-6: Calculation of IC50 values for propolis extracts in MCF12A cells. Each 
point shows the percent cell death at different concentrations of Propolis extracts. 
A, The IC50 value for Propolis-1 is 35 ug/ml and R
2 value is R2=0.8174. B, The IC50 
value for Propolis-2 is 45 ug/ml and R2 value is R2=0.8014. Error bars represent 
standard error of the mean (SEM). 
 
IC50 Values of Propolis extracts for MDA-MB-231 Cell line  
Analysis of IC50 value of propolis extracts on MDA-MB-231 was performed with 
following conditions: 
Propolis-1: 100-75-50-25-12.5-6 ug/ml, 4000 cells were used in each well. MDA-MB-
231  cell line’s IC50 value was calculated as 26 ug/ml (Figure 4-6, A). The experiment 
was performed in quadruplicate. 
Propolis-2: 150-120-75-60-37.5-30 ug/ml, 7000 cells were used in each well. MDA-
MB-231  cell line’s IC50 value was calculated as 74 ug/ml (Figure 4-6, B). The 
experiment was performed in quadruplicate. 
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The original data for ELISA reading results are given in Appendix Table 8.5 for 
Propolis-1 and Appendix Table 8.6 for Propolis-2. 
 
 
Figure 4-7 Calculation of IC50 values for propolis extracts in MDA-MB-231 cells. 
Each point shows the percent cell death at different concentrations of Propolis 
extracts. A, The IC50 value for Propolis-1 is 26 ug/ml and R
2 value is R2 =0.9072. B, 
The IC50 value for Propolis-2 is 74 ug/ml and R
2 value is R2 =0.8009. Error bars 
represent standard error of the mean (SEM). 
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IC50 Values of Propolis extracts for CAMA-1 Cell line  
Analysis of IC50 value of propolis extracts on CAMA-1  was performed with following 
conditions: 
Propolis-1: 80-60-50-40-30-25 ug/ml, 4000 cells were used in each well. CAMA-1  
cell line’s IC50 value was calculated as 25 ug/ml (Figure 4-8, A). The experiment was 
performed in quadruplicate. 
Propolis-2: 100-80-50-40-25-20 ug/ml, 4000 cells were used in each well. CAMA-1  
cell line’s IC50 value was calculated as 35 ug/ml (Figure 4-8, B). The experiment was 
performed in quadruplicate. 
The original data for ELISA reading results are given in Appendix Table 8.7 for 
Propolis-1 and Appendix Table 8.8 for Propolis-2. 
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Figure 4-8: Calculation of IC50 values for propolis extracts in CAMA-1 cells. Each 
point shows the percent cell death at different concentrations of Propolis extracts. 
A, The IC50 value for Propolis-1 is 25 ug/ml and R2 value is R2=0. 8977. B, The IC50 
value for Propolis-2 is 35 ug/ml and R2 value is R2=0. 9885. Error bars represent 
standard error of the mean (SEM). 
 
IC50 Values of Propolis extracts for MDA-MB-453 Cell line  
Analysis of IC50 value of propolis extracts on MDA-MB-453 was performed with 
following conditions: 
Propolis-1: 80-60-40-30-20 ug/ml, 4000 cells were used in each well. MDA-MB-453 
cell line’s IC50 value was calculated as 47 ug/ml (Figure 4-9, A). The experiment was 
performed in triplicate. 
Propolis-2: 120-100-60-50-30 ug/ml, 8000 cells were used in each well. MDA-MB-
453 cell line’s IC50 value was calculated as 53 ug/ml (Figure 4-9, B). The experiment 
was performed in quadruplicate. 
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The original data for ELISA reading results are given in Appendix Table 8.9 for 
Propolis-1 and Appendix Table 8.10 for Propolis-2. 
 
 
 
Figure 4-9: Calculation of IC50 values for propolis extracts in MDA-MB-453 cells. 
Each point shows the percent cell death at different concentrations of Propolis 
extracts. A, The IC50 value for Propolis-1 is 47 ug/ml and R2 value is R2=0. 9326. B, 
The IC50 value for Propolis-2 is 53 ug/ml and R2 value is R2=0. 9154. Error bars 
represent standard error of the mean (SEM). 
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IC50 Values of Propolis extracts for MDA-MB-468 Cell line  
Analysis of IC50 value of propolis extracts on MDA-MB-468 was performed with 
following conditions: 
Propolis-1: 80-60-40-30-20-15 ug/ml, 4000 cells were used in each well. MDA-MB-
468 cell line’s IC50 value was calculated as 30 ug/ml (Figure 4-10, A). The experiment 
was performed in quadruplicate. 
Propolis-2: 120-100-60-50-30 -25 ug/ml, 4000 cells were used in each well. MDA-
MB-468 cell line’s IC50 value was calculated as 26 ug/ml (Figure 4-10, B). The 
experiment was performed in quadruplicate. 
The original data for ELISA reading results are given in Appendix Table 8.11 for 
Propolis-1 and Appendix Table 8.12for Propolis-2. 
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Figure 4-10: Calculation of IC50 values for propolis extracts in MDA-MB-468  cells. 
Each point shows the percent cell death at different concentrations of Propolis 
extracts. A, The IC50 value for Propolis-1 is 30 ug/ml and R2 value is R2=0. 965. B, 
The IC50 value for Propolis-2 is 26 ug/ml and R2 value is R2=0. 971. Error bars 
represent standard error of the mean (SEM). 
 
IC50 Values of Propolis extracts for T47D Cell line  
Analysis of IC50 value of propolis extracts on T47D was performed with following 
conditions: 
Propolis-1: 80-60-50-40-30-25 ug/ml, 5000 cells were used in each well. T47D cell 
line’s IC50 value was calculated as 36 ug/ml (Figure 4-11, A). The experiment was 
performed in quadruplicate. 
Propolis-2: 100-80-50-40-25-20 ug/ml, 4000 cells were used in each well. T47D cell 
line’s IC50 value was calculated as 43 ug/ml (Figure 4-11, B). The experiment was 
performed in quadruplicate. 
The original data for ELISA reading results are given in Appendix Table 8.13 for 
Propolis-1 and Appendix Table 8.14 for Propolis-2. 
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Figure 4-11: Calculation of IC50 values for propolis extracts in T47D cells. Each 
point shows the percent cell death at different concentrations of Propolis extracts. 
A, The IC50 value for Propolis-1 is 36 ug/ml and R2 value is R2=0. 979. B, The IC50 
value for Propolis-2 is 43 ug/ml and R2 value is R2=0. 9602. Error bars represent 
standard error of the mean (SEM). 
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IC50 Values of Propolis extracts for MCF7 Cell line  
Analysis of IC50 value of propolis extracts on MCF7 was performed with following 
conditions: 
Propolis-1: 100-80-50-40-25-20  ug/ml, 3000 cells were used in each well. MCF7 cell 
line’s IC50 value was calculated as 41 ug/ml (Figure 4-12, A). The experiment was 
performed in quadruplicate. 
Propolis-2: 120-100-60-50-30 -25 ug/ml, 3000 cells were used in each well. MCF7 
cell line’s IC50 value was calculated as 61 ug/ml (Figure 4-12, B). The experiment was 
performed in quadruplicate. 
The original data for ELISA reading results are given in Appendix Table 8.15 for 
Propolis-1 and Appendix Table 8.16 for Propolis-2. 
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Figure 4-12: Calculation of IC50 values for propolis extracts in MCF7 cells. Each 
point shows the percent cell death at different concentrations of Propolis extracts. 
A, The IC50 value for Propolis-1 is 41 ug/ml and R2 value is R2=0. 9716. B, The IC50 
value for Propolis-2 is 61 ug/ml and R2 value is R2=0. 8951. Error bars represent 
standard error of the mean (SEM). 
 
IC50 Values of Propolis extracts for HCC-1937 Cell line  
Analysis of IC50 value of propolis extracts on HCC-1937 was performed with 
following conditions: 
Propolis-1: 150-120-75-60-37.5-30  ug/ml, 10000 cells were used in each well. HCC-
1937 cell line’s IC50 value was calculated as 123 ug/ml (Figure 4-13, A). The 
experiment was performed in quadruplicate. 
Propolis-2: 150-120-75-60-30 ug/ml, 8000 cells were used in each well. HCC-1937 
cell line’s IC50 value was calculated as 119 ug/ml (Figure 4-13, B). The experiment 
was performed in quadruplicate. 
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The original data for ELISA reading results are given in Appendix Table 8.17 for 
Propolis-1 and Appendix Table 8.18 for Propolis-2. 
 
 
 
Figure 4-13: Calculation of IC50 values for propolis extracts in HCC-1937 cells. Each 
point shows the percent cell death at different concentrations of Propolis extracts. 
A, The IC50 value for Propolis-1 is 123 ug/ml and R2 value is R2=0. 949. B, The IC50 
value for Propolis-2 is 119 ug/ml and R2 value is R2=0. 8847. Error bars represent 
standard error of the mean (SEM). 
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IC50 Values of Propolis extracts for MDA-MB-157 Cell line  
Analysis of IC50 value of propolis extracts on MDA-MB-157 was performed with 
following conditions: 
Propolis-1: 120-100-60-50-30 -25 ug/ml, 10000 cells were used in each well. MDA-
MB-157cell line’s IC50 value was calculated as 88 ug/ml (Figure 4-14, A). The 
experiment was performed in quadruplicate.  
Propolis-2: 150-120-75-60-37.5-30 ug/ml, 10000 cells were used in each well. MDA-
MB-157cell line’s IC50 value was calculated as 61 ug/ml (Figure 4-14, B). The 
experiment was performed in triplicate. 
The original data for ELISA reading results are given in Appendix Table 8.19 for 
Propolis-1 and Appendix Table 8.20 for Propolis-2. 
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Figure 4-14: Calculation of IC50 values for propolis extracts in MDA-MB-157cells. 
Each point shows the percent cell death at different concentrations of Propolis 
extracts. A, The IC50 value for Propolis-1 is 88 ug/ml and R2 value is R2=0. 9018. B, 
The IC50 value for Propolis-2 is 61 ug/ml and R2 value is R2=0. 9429. Error bars 
represent standard error of the mean (SEM). 
 
IC50 Values of Propolis extracts for BT-20 Cell line  
Analysis of IC50 value of propolis extracts on BT-20 was performed with following 
conditions: 
Propolis-1: 150-120-75-60-37.5-30 ug/ml, 12000 cells were used in each well. BT-20 
cell line’s IC50 value was calculated as 73 ug/ml (Figure 4-15, A). The experiment was 
performed in quadruplicate. 
Propolis-2: 120-100-60-50-30 ug/ml, 12000 cells were used in each well. BT-20 cell 
line’s IC50 value was calculated as 117 ug/ml (Figure 4-15, B). The experiment was 
performed in triplicate. 
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The original data for ELISA reading results are given in Appendix Table 8.21 for 
Propolis-1 and Appendix Table 8.22 for Propolis-2. 
 
 
 
Figure 4-15: Calculation of IC50 values for propolis extracts in BT-20 cells. Each 
point shows the percent cell death at different concentrations of Propolis extracts. 
A, The IC50 value for Propolis-1 is 73 ug/ml and R2 value is R2=0. 9444. B, The IC50 
value for Propolis-2 is 117 ug/ml and R2 value is R2=0. 8773. Error bars represent 
standard error of the mean (SEM). 
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IC50 Values of Propolis extracts for MDA-MB-361 Cell line  
Analysis of IC50 value of propolis extracts on MDA-MB-361 was performed with 
following conditions: 
Propolis-1: 80-60-40-30-20-15 ug/ml, 20000 cells were used in each well. MDA-MB-
361 cell line’s IC50 value was calculated as 51 ug/ml (Figure 4-16, A). The experiment 
was performed in quadruplicate. 
Propolis-2: 150-120-75-60-37.5-30 ug/ml, 20000 cells were used in each well. MDA-
MB-361 cell line’s IC50 value was calculated as 57 ug/ml (Figure 4-16, B). The 
experiment was performed in quadruplicate. 
The original data for ELISA reading results are given in Appendix Table 8.23 for 
Propolis-1 and Appendix Table 8.24 for Propolis-2. 
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Figure 4-16: Calculation of IC50 values for propolis extracts in MDA-MB-361 cells. 
Each point shows the percent cell death at different concentrations of Propolis 
extracts. A, The IC50 value for Propolis-1 is 51 ug/ml and R2 value is R2=0. 9212. B, 
The IC50 value for Propolis-2 is 57 ug/ml and R2 value is R2=0. 9433. Error bars 
represent standard error of the mean (SEM). 
 
IC50 Values of Propolis extracts for BT-474 Cell line  
Analysis of IC50 value of propolis extracts on BT-474 was performed with following 
conditions: 
Propolis-1: 150-120-75-60-37.5-30 ug/ml, 20000 cells were used in each well. BT-
474 cell line’s IC50 value was calculated as 50 ug/ml (Figure 4-17, A). The experiment 
was performed in triplicate. 
Propolis-2: 150-120-75-60-37.5-30 ug/ml, 10000 cells were used in each well. BT-
474 cell line’s IC50 value was calculated as 92 ug/ml (Figure 4-17, B). The experiment 
was performed in triplicate. 
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The original data for ELISA reading results are given in Appendix Table 8.25 for 
Propolis-1 and Appendix Table 8.26 for Propolis-2. 
 
 
 
Figure 4-17: Calculation of IC50 values for propolis extracts in BT-474 cells. Each 
point shows the percent cell death at different concentrations of Propolis extracts. 
A, The IC50 value for Propolis-1 is 50 ug/ml and R2 value is R2=0. 9317. B, The IC50 
value for Propolis-2 is 92 ug/ml and R2 value is R2=0. 9517. Error bars represent 
standard error of the mean (SEM). 
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IC50 Values of Propolis extracts for ZR-75-1 Cell line  
Analysis of IC50 value of propolis extracts on ZR-75-1 was performed with following 
conditions: 
Propolis-1: 120-100-80-75-60-50 ug/ml, 5000 cells were used in each well. ZR-75-1 
cell line’s IC50 value was calculated as 73 ug/ml (Figure 4-18, A). The experiment was 
performed in quadruplicate. 
Propolis-2: 120-100-60-50-30 ug/ml, 6000 cells were used in each well. ZR-75-1 cell 
line’s IC50 value was calculated as 76 ug/ml (Figure 4-18, B). The experiment was 
performed in triplicate. 
The original data for ELISA reading results are given in Appendix Table 8.27 for 
Propolis-1 and Appendix Table 8.28 for Propolis-2. 
 
 
A 
71 
 
 
Figure 4-18: Calculation of IC50 values for propolis extracts in ZR-75-1 cells. Each 
point shows the percent cell death at different concentrations of Propolis extracts. 
A, The IC50 value for Propolis-1 is 73 ug/ml and R2 value is R2=0. 9423. B, The IC50 
value for Propolis-2 is 76 ug/ml and R2 value is R2=0. 8916. Error bars represent 
standard error of the mean (SEM). 
 
IC50 Values of Propolis extracts for hTERT-HME-1 Cell line  
Analysis of IC50 value of propolis extracts on hTERT-HME-1 was performed with 
following conditions: 
Propolis-1: 120-100-60-50-30 ug/ml, 6000 cells were used in each well. hTERT-HME-
1 cell line’s IC50 value was calculated as 41 ug/ml (Figure 4-19, A). The experiment 
was performed in quadruplicate. 
Propolis-2: 150-120-75-60-37.5 ug/ml, 6000 cells were used in each well. hTERT-
HME-1 cell line’s IC50 value was calculated as 114 ug/ml (Figure 4-19, B). The 
experiment was performed in triplicate. 
The original data for ELISA reading results are given in Appendix Table 8.29 for 
Propolis-1 and Appendix Table 8.30 for Propolis-2. 
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Figure 4-19: Calculation of IC50 values for propolis extracts in hTERT-HME-1 cells. 
Each point shows the percent cell death at different concentrations of Propolis 
extracts. A, The IC50 value for Propolis-1 is 41 ug/ml and R2 value is R2=0. 8443. B, 
The IC50 value for Propolis-2 is 114 ug/ml and R2 value is R2=0. 8783. Error bars 
represent standard error of the mean (SEM). 
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4.3 Association of IC50 Values of Propolis extracts with 
Properties of Breast Carcinoma Cell Lines 
 
Previously calculated IC50 values of propolis extracts for breast carcinoma cell lines 
were classified according to cell lines’ molecular properties (Table 4.5). Statistical 
analysis was performed to analyze whether there is any correlation between IC50 
values of propolis and the molecular status of cell line with Microsoft Excel program 
by using T.TEST function. Student’s t-test was calculated with two-tailed distribution 
and two-sample unequal variance. Fold change of propolis extracts was calculated 
by dividing IC50 values of Propolis-2 extract to IC50 values of Propolis-1 extract(Figure 
4-20 and Figure 4-21). 
 
 
Table 4.5 Classification of Breast carcinoma cell lines According to Their Molecular 
Status with IC50 Values of Propolis Extracts (Neve, 2006; Kao, 2009; Finn, 2009; 
Holliday, 2011). 
Cell Lines  
 IC50 (ug/ml) Molecular Status of Cell Lines 
Propolis-
1 
Propolis-
2 
Subtype 
Estrogen 
Receptor (ER)  
Progesterone 
Receptor (PR)  
HER2  
BT-20 73 117 basal A negative negative normal 
BT-474 50 92 luminal B positive positive amplified 
CAMA-1 25 35 luminal positive negative normal 
HCC-1937 123 119 basal A negative negative normal 
hTERT-HME1 41 114 basal B negative n/a negative 
MCF10A 45 72 basal B negative negative immortalized 
MCF12A 35 45 basal B negative negative n/a 
MCF7 41 61 luminal A positive positive normal 
MDA-MB 231 26 74 basal B negative negative normal 
MDA-MB-157 88 61 basal B negative negative normal 
MDA-MB-361 51 57 luminal positive positive amplified 
MDA-MB-453 47 53 luminal negative negative amplified 
MDA-MB-468 30 26 basal A negative negative normal 
T47D 36 43 luminal A positive positive normal 
ZR-75-1 73 76 luminal B positive negative normal 
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Figure 4-20 Comparison of IC50 Values of Two Different Propolis Extracts on Breast 
carcinoma cell lines 
 
 
Figure 4-21 Fold change of IC50 values of two different propolis extracts on breast 
carcinoma cell lines (p= 0,0016, IC50 values of Propolis-2 are significantly higher 
than IC50 values of Propolis-1). 
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The result showed that IC50 values of Propolis-2 extract were significantly higher 
than IC50 values of Propolis-1 extract among all cell lines. Pearson correlation was 
also calculated and the resulted correlation was found as significant at the 0.05 
level (2-tailed). 
 
The calculated IC50 for each cell line was analyzed for the cell lines molecular 
classification groups. Basal cell line group was compared to luminal cell lines to 
analyze if there is any significant difference between the subgroups responding to 
propolis extracts. The results showed that there is no significant correlation 
between these two groups for any of the two extracts (Propolis-1, p=0.4 and 
Propolis-2, p=0.2). 
 
 
 
Figure 4-22 IC50 values of propolis extracts were used to analyze according to the 
molecular subtypes of breast carcinoma cell lines. Basal cell line group was 
compared to luminal cell line group for both Propolis-1 and Propolis-2 (Propolis-1, 
p=0.4 and Propolis-2, p=0.2).   
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The calculated IC50 for each cell line was analyzed for ER status (positive/negative) 
of the breast carcinoma cell lines.  The results showed that there is no significant 
correlation between these two groups for any of the two extracts (Propolis-1, p=0.4 
and Propolis-2, p=0.3). 
 
 
 
Figure 4-23 IC50 values of propolis extracts were used to analyzed according to the 
ER status of breast carcinoma cell lines. ER positive cell line group was compared to 
ER negative cell line group for both Propolis-1 and Propolis-2 (Propolis-1, p=0.4 and 
Propolis-2, p=0.3). 
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The calculated IC50 for each cell line was analyzed for PR status (positive/negative) 
of the cell lines. The results showed that there is no significant correlation between 
these two groups for any of the two extracts (Propolis-1, p=0.3 and Propolis-2, 
p=0.8). 
 
 
 
Figure 4-24 IC50 values of propolis extracts were used to analyzed according to the 
PR status of breast carcinoma cell lines. PR positive cell line group was compared 
to PR negative cell line group for both Propolis-1 and Propolis-2 (Propolis-1, p=0.3 
and Propolis-2, p=0.8). 
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The calculated IC50 for each cell line was analyzed for HER2 status 
(normal/amplified) of the cell lines. The results showed that there is no significant 
correlation between these two groups for any of the two extracts (Propolis-1, p=0.5 
and Propolis-2, p=1.0). 
 
 
 
Figure 4-25 IC50 values of propolis extracts were used to analyzed according to the 
HER2 status of breast carcinoma cell lines. HER2 normal cell line group was 
compared to HER2 amplified cell line group for both Propolis-1 and Propolis-2 
(Propolis-1, p=0.5 and Propolis-2, p=1.0).  
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4.4 Dynamic Cell Proliferation of Propolis Treated Cells with 
xCELLigence 
 
The xCELLigence Systems allow for label-free and real-time monitoring of cellular 
processes such as cell proliferation. The cell growth curves were automatically 
recorded on the xCELLigence System in real time. IC50 value calculations were 
restricted to the one time point whereas response to a treatment is dynamic 
phenomena. Therefore observing the effect of propolis on growing cells (real-time) 
is an important analysis. xCELLigence (Roche) system was used to monitor the 
growing cells in real time. Dynamic monitoring of the logarithmic growth of the cells 
was correlated with cell index (CI). Cells were inoculated to E plate 96 with indicated 
cell numbers and experiments were performed in triplicate (Table 4.6). Cells were 
monitored and measurements were collected every 10 minutes. When the cell 
index reaches to 0,75 before it exceeds the cell index 1,20, cells were treated with 
three different Propolis extract-2 concentrations (IC50 values, half and double of IC50 
values of each cell line) and control DMSO. Then the measurements were collected 
for every 30 min for minimum of 72 h. DMSO amount was adjusted in each 
propolis-2 concentration to the same dilution so that only one control DMSO 
dilution was used. The logarithmic growth of each cell line was given from Figure 
4-26 to Figure 4-31. 
Table 4.6 Starting Cell Numbers of Cell Lines for xCELLigence Monitoring 
Cell Line Starting Cell Numbers 
MCF10A 2000 cells/well 
BT-474 4000 cells/well 
T47D 2000 cells/well 
BT-20 2000 cells/well 
CAMA-1 4000 cells/well 
MDA-MB-231 3000 cells/well 
80 
 
 
Figure 4-26 Dynamic monitoring of cell proliferation using the xCELLigence system 
in MCF10A. MCF10A (IC50=72 ug/ml) cells treated with propolis-2 at 32.5 ug/ml, 65 
ug/ml, and 130ug/ml concentrations and control DMSO. The arrow shows the time 
point where the propolis-2 and DMSO were added to the cells.  
 
Figure 4-27 Dynamic monitoring of cell proliferation using the xCELLigence system 
in BT-474. BT-474 (IC50= 92 ug/ml) cells treated with propolis-2 at 47.5 ug/ml, 
95ug/ml and 190ug/ml concentrations and control DMSO. The arrow shows the 
time point where the propolis-2 and DMSO were added to the cells.  
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Figure 4-28 Dynamic monitoring of cell proliferation using the xCELLigence system 
in T47D. T47D (IC50= 43 ug/ml) cells treated with propolis-2 at 20 ug/ml, 40ug/ml 
and 80ug/ml concentrations and control DMSO. The arrow shows the time point 
where the propolis-2 and DMSO were added to the cells.  
 
 
Figure 4-29 Dynamic monitoring of cell proliferation using the xCELLigence system 
in BT-20. BT-20 (IC50= 117 ug/ml) cells treated with propolis-2 at 55 ug/ml, 110 
ug/ml and 220ug/ml concentrations and control DMSO. The arrow shows the time 
point where the propolis-2 and DMSO were added to the cells.  
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Figure 4-30 Dynamic monitoring of cell proliferation using the xCELLigence system 
in CAMA-1. CAMA-1 (IC50= 35 ug/ml) cells treated with propolis-2 at 17.5 ug/ml, 
35ug/ml and 70ug/ml concentrations and control DMSO. The arrow shows the time 
point where the propolis-2 and DMSO were added to the cells.  
 
 
Figure 4-31 Dynamic monitoring of cell proliferation using the xCELLigence system 
in MDA-MB-231. MDA-MB-231 (IC50= 74 ug/ml) cells treated with propolis-2 at 37.5 
ug/ml, 75ug/ml and 150ug/ml concentrations and control DMSO. The arrow shows 
the time point where the propolis-2 and DMSO were added to the cells.  
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Real Time Growth Curves of breast carcinoma cell lines with different 
concentrations of propolis-2 were monitored by xCelligence system. The arrow 
shows the time point where the propolis-2 and control DMSO were added to the 
cells.  
All the cell lines , except CAMA1, showed decrease in growth rate compare to only 
DMSO treated cells.  Increasing concentrations of propolis-2 was decreases the cell 
number in a dose- and  cell line- dependent way.  
 
 
4.5 Propolis Induces Apoptosis on Breast Carcinoma Cell Lines 
 
The observation of propolis anti-proliferative effect led us to evaluate its cellular 
mechanism. To evaluate the anti-proliferative effects of propolis , the cell lines were 
analyzed for cell death. 
 
4.5.1 Morphology of the Cells Changes with Propolis Treatment 
 
The cells were treated with propolis and their morphology was observed under the 
light microscope. Morphological changes indicate apoptotic cell death. The effected 
cells were changed their adherent morphology to round cells and after a few hours 
later, those round cells were detached from the surface of the plate. 
Breast carcinoma cell lines were cultured on 6 well plates as 80,000 cells/well. The 
cells were treated with either 0.1 % DMSO or 100 ug/ml Propolis-2 after 24 hours. 
The cells were observed under light microscope and photos were taken with 10X 
magnification, 48 hours after the treatment (Figure 4-32). 
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A-1 ) MCF10A, DMSO    A-2 ) MCF10A, Propolis 
  
 
B-1 ) MDA-MB-231, DMSO   B-2 ) MDA-MB-231, Propolis 
  
 
C-1 ) T47D, DMSO     C-2 ) T47D, Propolis  
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D-1 ) BT-20, DMSO     D-2 ) BT-20, Propolis 
  
E-1 ) BT-474, DMSO     E-2 ) BT-474, Propolis 
  
F-1 ) CAMA-1, DMSO, 10X   F-2 ) CAMA-1, Propolis, 10X 
  
Figure 4-32 The morphological appearance of treated cell lines under the light 
microscope. The cells were treated with 100 ug/ml Propolis and 0.1% DMSO control 
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and the photos were taken after 48 h of treatment. MCF10A (A), MDA-MB-231 (B), 
T47D (C), BT-20 (D), BT-474 (E), CAMA-1 (F), (10X magnification). 
 
Cell death effect of propolis in cell lines were evaluated by treating cells with 
propolis and the morphology of the cells were observed under light microscope. 
The cell morphology changed after treatment. It was observed that the cells 
become more round and the cell edges were sharper than control cells. The 
increased number of round and detached cells were observed which made the 
apoptosis as a suspected cell death mechanism. 
 
4.5.2 Chromatin Condensation and Nuclear Fragmentation 
 
To analyze the apoptosis the Propolis and DMSO treated cells were stained with 
well-known nuclear dye Hoechst 33258 and common properties of apoptotic cells, 
chromatin condensation and nuclear fragmentation, were observed.  
The cells were seeded onto glass coverslips in 6 well plates as 80,000 cells/well and 
24 hours later, cells were treated with either 0.1 % DMSO or 100 ug/ml Propolis-2. 
Cells were stained with Hoechst 33258, 48 hours after the treatment. Photos were 
taken under fluorescent microscope with 40X magnification (Figure 4-33). 
Condensed chromatins were identified by their intense staining while normal cells 
can be depicted with clear and uniformly dispersed nuclei. In DMSO control treated 
cells, the nucleolus could be observed ( black dots in the cells) . White arrows in the 
pictures indicate apoptotic cells with condensed chromatin and red circles indicate 
the dividing cells. The bold white arrow in Figure 4-33, C-2 shows the nuclear 
fragmented apoptotic cell. 
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Figure 4-33 Hoechst 33258  staining and morphological appearance of cell nucleus 
after treatment. The MCF10A (A), MDA-MB-231 (B), T47D (C), BT-20 (D), CAMA-1 
(E) cells were incubated with Propolis-2 with either 0.1% DMSO (1) or 100 ug/ml 
Propolis-2 (2) for 48 h.  Then the cells were stained with Hoechst 33258. Photos 
were taken under the flourescent microscope with 40X magnification. Chromatin 
condensations were indicated with arrows, red circles indicate dividing cells, and big 
white arrow in C-2 shows the nuclear fragmented apoptotic cells. 
 
The result showed that there is an increase in the number of apoptotic cells when 
they were treated with propolis. 
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4.5.3 Western Blot Analysis of PARP-1 cleavage  
 
The Poly (ADP-Ribose) Polymerase 1 (PARP-1) is an ADP-ribosylating enzyme 
essential for initiating various forms of DNA repair. PARP-1, a 116 kDa nuclear 
enzyme, is cleaved in fragments of 89 and 24 kDa during apoptosis. This cleavage 
has become a useful hallmark of apoptosis. Western blot analysis was performed to 
detect the PARP-1 cleavage in propolis treated cells. Cells were seeded on 6 well 
plates as 80,000 cells/well and cells were treated with either 0.1 % DMSO or 100 
ug/ml Propolis-2 after 24 hours. Cell pellets were collected after 48 hours of 
treatment. Protein extraction was performed and 50 ug proteins were run in SDS-
PAGE. PARP-1 protein was detected in the membranes and β-actin was used as 
equal loading control (Figure 4-37). The PARP-1 antibody can both target the full 
length PARP-1 (116 kDa) as well as its cleaved fragment (89 kDa). The image photos 
were analyzed with ImageJ software to obtain quantified, comparable data. Each 
band’s intensity was quantified by using ImageJ to obtain numerical results of its 
intensity. Each sample’s normalization was calculated by dividing its PARP-1 protein 
band intensity to its β-actin protein band intensity (from Figure 4-38 to Figure 4-36).  
  
Figure 4-34 Western blot analysis of PARP-1 cleavage in untreated and Adriamycin 
treated breast carcinoma cell lines. Untreated cell lines (left), Adriamycin treated 
(as a positive control) cells (right) were analysed for their PARP-1 protein cleavage. 
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Figure 4-35 Graphical representation of normalized data of PARP-1 band 
intensities in untreated breast carcinoma cell lines. Each sample’s normalization 
was calculated by dividing its full length PARP-1 protein (116 kDa) band intensity to 
its β-actin protein (42 kDa) band intensity (left) and  cleaved PARP-1 protein (89 
kDa) band intensity to its β-actin protein (42 kDa) band intensity (right)(images from 
Figure 4-34).  
 
  
Figure 4-36 Graphical representation of normalized data of PARP-1 band 
intensities in untreated and Adriamycin treated MDA-MB-231 cells. Each sample’s 
normalization was calculated by dividing its full length PARP-1 protein (116 kDa) 
band intensity to its β-actin protein (42 kDa) band intensity (left) and  cleaved PARP-
1 protein (89 kDa) band intensity to its β-actin protein (42 kDa) band intensity 
(right)(images from Figure 4-34).  
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Adriamycin is a well know DNA damaging drug that directly intercalates into double-
stranded DNA. It prevents DNA replication and induces apoptosis therefore 
Adriamycin was used as a positive control of apoptosis. In the increasing amount of 
Adriamycin treatment, PARP-1 full length as well as cleaved  fragment of PARP-1 
were  decreased. 
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Figure 4-37 Western blot analysis of PARP-1 cleavage in DMSO and Propolis-2 
treated breast carcinoma cell lines. Adriamycin treated cells were analysed for 
their PARP-1 protein cleavage as a positive control. 
 
The propolis treated sample intensity was compared to DMSO control sample 
intensity for PARP-1 changes after β-actin normalization. 
 
 
Figure 4-38 Graphical representation of normalized data of full length PARP-1 
band intensity in breast carcinoma cell lines. Each sample’s normalization was 
calculated by dividing its full length PARP-1 protein (116 kDa) band intensity to its β-
actin protein (42 kDa) band intensity (images from Figure 4-37).  
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Figure 4-39 Graphical representation of normalized data of cleaved PARP-1 band 
intensity in breast carcinoma cell lines. Each sample’s normalization was calculated 
by dividing its cleaved fragment of PARP-1 protein (89 kDa) band intensity to its β-
actin protein (42 kDa) band intensity (images from Figure 4-37). 
 
Decrease in the full length PARP-1 protein levels (except MDA-MB-231 cell line) 
supports our hypothesis that propolis treated cells enter to apoptotic state. 
Increase in the cleaved PARP-1 was observed only in MDA-MB-231 and BT-20 cell 
lines. To analyze the relative effect of full length and cleaved PARP-1 protein levels, 
another analysis was performed by calculating the intensity ratio of full length 
PARP-1 and cleaved PARP-1 proteins. Since the analysis gave an expected result 
with positive control samples (Figure 4-40), the same analysis was performed with 
propolis and control DMSO treated cells (). 
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Figure 4-40 Graphical representation of normalized data of full length PAPR-1 and 
cleaved PARP-1 band intensity ratio in untreated and Adriamycin treated MDA-
MB-231 cells. Each sample’s ratio was calculated by dividing its full length PARP-1 
protein (116 kDa) band intensity to cleaved PARP-1 protein (89 kDa) band intensity 
(images from Figure 4-34).  
 
Figure 4-41 Graphical representation of normalized data of full length PAPR-1 and 
cleaved PARP-1 band intensity ratio in breast carcinoma cell lines. Each sample’s 
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ratio was calculated by dividing its full length PARP-1 protein (116 kDa) band 
intensity to cleaved PARP-1 protein (89 kDa) band intensity (images from Figure 
4-37). 
 
MDA-MB-231, CAMA-1, BT-20 and BT-474 cell lines were showed a decrease in the 
ratio of full length PAPR-1 over cleaved PAPR-1 protein band intensity which 
supports the apoptosis possibility of cell death mechanism. 
  
 
 
4.6 Propolis Slightly Increases G2/M arrest of MDA-MB-231 
Cells 
 
The effect of propolis on cell cycle was analyzed with flow cytometer. MDA-MB-231 
cells were seeded on 6 well plates (80,000 cells/well) and 24 hours later, cells were 
treated with DMSO, 75 ug/ml Propolis-2 (IC50 value for this cell line), 250 ng/ ml 
Adriamycin (as a positive control for G2/M arrest) or untreated (control for 
Adriamycin treated cells) for 72 hours. Cell pellets were maintained and stained 
with Propidium Iodide (PI) and stained cells were counted with flow cytometer.  
Initially, the Adriamycin treated MDA-MB-231 cells were analyzed with flow 
cytometer as a control experiment to observe cell cycle changes. The cells were 
treated with Adriamycin for 72 hours (Figure 4-42).  
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Figure 4-42 Cell cycle analysis of untreated and Adriamycin treated MDA-MB-231 
cell line with flow cytometer. Untreated cells (A) and Adriamycin treated cells (B). 
The cell cycle phases were represented in the histogram as M1: Sub-G1; M2: G1; 
M3: S; M4: G2/M.  
 
A B 
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Figure 4-43 Graphical representation of cell cycle analysis of untreated and 
Adriamycin treated MDA-MB-231 cell line. Data in Figure 4-42. was used to show 
the cell cycle phase differences between untreated and Adriamycin treated cells. 
 
It was observed that the Adriamycin treated cells were entered G2/M cell cycle 
arrest. After this control experiment, the same analysis was performed with DMSO 
and propolis treated MDA-MB-231 cells.  
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Figure 4-44 Cell cycle analysis of DMSO and propolis treated MDA-MB-231 cell line 
with flow cytometer. DMSO treated cells (A) and Propolis-2 treated cells (B). The 
cell cycle phases were represented in the histogram as M1: Sub-G1; M2: G1; M3: S; 
M4: G2/M.  
A B 
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Figure 4-45 Graphical representation of cell cycle analysis DMSO and propolis 
treated MDA-MB-231 cell line. Data in Figure 4-44. was used to show the cell cycle 
phase differences between DMSO and propolis treated cells.  
 
Table 4.7 Percent gate comparison of untreated, DMSO, propolis and Adriamycin 
treated MDA-MB-231 cell line for cell cycle analysis. Data was taken from Figure 
4-42 an Figure 4-44. 
% Gate Untreated DMSO Propolis Adriamycin 
Sub-G1 0.65 0.49 1.18 1.36 
G1 68.87 67.65 53.75 13.07 
S 10.81 9.98 15.63 11.16 
G2/M 19.99 21.28 27.49 72.4 
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Figure 4-46 Graphical representation of cell cycle analysis of untreated, DMSO, 
propolis and Adriamycin treated MDA-MB-231 cell line. Data was taken from 
Figure 4-42 an Figure 4-44. 
 
Above analyses demonstrate that propolis treatment induces G2/M arrest of MDA-
MB-231 cell line. 
 
4.7 Propolis Blocks Invasion of MDA-MB-231 Cells 
 
The in vitro scratch assay (wound healing assay) is an easy, low-cost and well-
developed method to measure cell invasion in vitro.  A straight line of cells are 
scraped from the plate and the invasion of the cells through this scraped line is 
observed via light microscope. 
FBS concentration in the growth medium was dropped from 10 % to 0.1 % to 
prevent cells growing through the scratch. By this way, wound healing assay can 
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display the invasion properties of cells but not the proliferation. There were 6 
conditions for this set up to observe the invasion rate: 
 10 % FBS containing growth medium treated cells (untreated, mock cells) to 
observe the effect of proliferation and compare it with 0.1 %  FBS medium 
treated cells, 
 0.1 % FBS containing growth medium treated cells to observe the effect of 
decreased FBS and compare it with DMSO control cells, 
 0.1 % FBS + 0.1 % DMSO containing growth medium treated cells as a 
control for propolis treated cells, 
 0.1 % FBS + 50, 75 (IC50 value propolis for MDA-MB-231 cells) and 100 ug/ml 
Propolis-2 containing growth medium treated cells to see the effect of 
gradually increasing concentrations of propolis on cell invasion ability. 
 
Cells (500,000 cells/well) were seeded in 6 well plate to obtain high confluency and 
24 hours later, scratches were made with a 200 ul micropipette tip. Cells were 
washed with 1X PBS twice to get rid of cell debris in the medium and then cells 
were treated with the growth mediums listed above. Right after the scratches were 
performed, time zero photos were taken to observe the scratches borders clearly. 
Then, the photos were taken at  6, 12, 24, 36 and 48 h intervals under the light 
microscope with 10X magnification. 
As shown in Figure 4-47, cells treated with propolis shows decreased invasion rate 
of the cells to the denuded area when compared to the DMSO control cells. 
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EMPTY PAGE 
 
 
 
 
 
 
 
 
Figure 4-47 Light microscope image to evaluate wound healing in vitro in the 
scratch assay using a confluent monolayer of MDA-MB-231 Cells. Cell migration 
into the wound was observed in response to an artificial injury of the cells. 
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5 Discussion 
 
The aim of this study was to evaluate the organic compound propolis effect on 
cancer cells. We are interested in the effects of propolis on cell growth in human 
cancer cells, as predictors of novel agents that may be useful in cancer 
chemoprevention or therapy. In recent years, it has been shown that propolis have 
antiviral, antimicrobial and antifungal and anti-carcinogenic activity (Sun, 2012). 
Propolis is a resinous material gathered by honeybees from the buds, leaf and bark 
of certain trees and plants. It is claimed to improve human health and prevent 
diseases, such as diabetes, inflammation and cancer (Viuda-Martos, 2008). There 
are many studies conducted on propolis or its active components for treatment of 
cancer which reveals the potential of this biological compound in the development 
of novel anti-cancerous agents (Markiewicz-Zukowska, 2013). Chemical analysis 
indicated that propolis is a multicomponent mixture of various compounds with 
prevalence of flavonoids and phenolic acids. Therefore it  is important to investigate 
the propolis extract mechanisms of action in order to predict possible toxic and may 
be therapeutic effects. The information may help us to develop new drugs that are 
even more effective for the prevention and treatment of cancer. 
In this study, the inhibitory effects of propolis collected from different regions of 
Turkey were analyzed on the growth of the human breast carcinoma cells. Two 
different extracts of propolis used in this study were provided by Prof. Dr. Orhan 
Deger at Karadeniz Technical University, Medical Biology Department.  The propolis 
was extracted and diluted in DMSO and added to the cultures.  
Initial experiments to evaluate the effect of propolis on cancer cells was analyzed 
with low concentrations (100-2000 ng/ml). The low concentrations did not show 
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any significant effect on cancer cells. One of the reasons can be the very low cell 
number of the living cells at the end of incubation period. However, the studies 
conducted so far show that propolis from different regions of the world are 
cytotoxic to cancer cells for different specific isolates of the extract with differing 
concentrations. Therefore, the analysis was repeated with higher concentrations of 
propolis and the result was promising. After the most effective incubation period 
was determined as 72 hours, the following experiments were conducted with 72 
hour incubation. The starting analysis was done with hepatocellular carcinoma cells, 
lung cancer cells, breast cancer cells as well as normal breast cell line and higher 
concentrations (25-50-75 ug/ml) of propolis were found to be significantly 
increasing the cell death among cancer cell lines. However, we decided to focus on 
one cancer type, breast cancer, to carry on further analysis. 
The first step of screening was performed with breast carcinoma cell line panel by 
calculating the IC50 values of propolis on each breast carcinoma cell line. The 
resulting IC50 values of 15 breast carcinoma cell lines for Propolis-1 extract were 
found to be ranging from 25 ug/ml to 123 ug/ml. Since propolis is a biological 
compound, a new propolis extract (Propolis-2) was also screened with the same 
breast carcinoma cell line panel by calculating the IC50 values to confirm that the 
effect of propolis. In this case, IC50 values of those breast carcinoma cell lines for 
Propolis-2 extract were found to be ranging from 26 ug/ml to 119 ug/ml. We 
concluded that propolis is cytotoxic to breast cancer cells with dose-dependent 
manner. 
Student’s t-test and Pearson correlation analyses show that there is significant 
increase in the IC50 values of Propolis-2 extract on breast carcinoma cell lines when 
compared with the IC50 values of Propolis-1 extract. This result may stem from the 
nature of a biological compound which can display fluctuating results according to 
the different propolis collections. Since propolis is a mixture of many compounds, 
plants that bees collect the propolis from may influence the effects on composition 
of propolis. Even the season that propolis collected in has an effect on active 
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components of propolis (Barlak, 2011). Because of these reasons, having different 
results from different extracts of a biological compound is inevitable. 
Another statistical analysis was processed to assess the possible correlation 
between molecular properties of different breast carcinoma cell lines and their IC50 
values for propolis extracts. Student’s t-test results show that there is no significant 
correlation between subtypes of breast carcinoma cell lines and IC50 values of 
propolis extracts. ER status as well as PR status and HER2 status of breast carcinoma 
cell lines do not result in a significant correlation with IC50 values of propolis 
extracts. We concluded that there is not a significant correlation between the 
cytotoxic effect of propolis extracts with different molecular properties of breast 
carcinoma cell lines.  
xCELLigence analysis is a powerful method to show the effect of drug on living cells. 
In this study, real time monitoring was a confirmative assay to show the effect of 
propolis on breast carcinoma cell lines. xCELLigence analysis shows the effect of 
propolis on cells in a short time intervals whereas SRB experiments can be 
performed only one particular time point. Results support the cytotoxicity of 
propolis on breast carcinoma cells. We could see the gradual decrease in the cell 
number as the concentration of propolis increases. Lower concentration of propolis 
behaves similar to control treatments however high concentrations of propolis 
almost kill all the cells after 72-100 hours. Also SRB measurements were correlated 
with this experiment. Other than T47D and CAMA-1 cell lines, the result showed 
that IC50 calculations had a similar effect on both SRB staining and xCELLigence 
experiments. This data reveals that propolis has cytotoxic effects on breast 
carcinoma cells and this effect is dose- and time- dependent.  
Induction of apoptosis in cancer cells is an important mechanism to eliminate the 
cancer cells. Since propolis extracts were toxic to the carcinoma cells, we evaluated 
the apoptosis effect of propolis in cell lines. To reveal if propolis effects apoptosis 
the cells were treated with the compound and the morphology of the cells were 
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first evaluated under light microscope and then stained with Hoechst, evaluated 
under fluorescence microscope. The cell morphology changed after treatment. It 
was observed that the cells become more round and the cell edges were sharper 
than control cells. The increased number of round and detached cells were 
observed. The Hoechst staining was performed to evaluate this observation. The 
staining results showed chromatin condensation and partial nuclear fragmentation 
in some cells. These data strengthen the hypothesis that Turkish propolis cytotoxic 
effect resulted with cell death through apoptosis.  
To further support this hypothesis, PARP-1 protein cleavage was investigated with 
western blot analysis. PAPR-1 is a well-known marker protein for apoptosis. The 
cleavage of PARP-1 into 89 kDa and 24 kDa fragments is another reliable marker of 
apoptotic cells (Chaitanya, 2010). Adriamycin was used as a positive control of 
apoptosis (Bilim, 1997). The Western blot results reveal that majority of the breast 
carcinoma cell lines had less amount of full length PARP-1 protein when treated 
with propolis than DMSO. The decrease in full length PARP-1 protein amount in 
propolis treated cells indicates the apoptosis was taken place  in the cells. However 
we could not see a significant increase in the apoptotic 89 kDa PARP-1 fragment 
when compared with control cells. Therefore further analysis are required to 
confirm the cell western blot analysis. Caspase-3 or 7 activities can be detected or 
other apoptotic markers can be analyzed. Also to eliminate the necrosis as a cell 
death another PARP-1 western blot analysis can be done with a different antibody 
which can recognize the 50 kDa fragment of PARP-1 protein which is associated 
with necrosis (Buontempo, 2010). Although increase in the amount 89 kDa cleaved 
protein was not clearly observed in propolis treated cells, observation of decrease 
in the full length PARP-1 protein after treatment shows that apoptosis takes place in 
these cell lines. Another analysis which compares the ratio of full length PAPR-1 
over cleaved PARP-1 protein band intensity showed a better result for supporting 
the apoptosis. MDA-MB-231, CAMA-1, BT-20 and BT-474 cell lines were found to 
have decreased  ratio of full length PAPR-1 over cleaved PARP-1 protein band 
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intensity which combines the expected result of decrease in the full length PAPR-1 
band intensity while increase in the cleaved PAPR-1 band intensity. 
The effect of propolis on cell cycle was also analyzed  by flow cytometer. In this 
assay Adriamycin treated cells were used as a positive control for G2/M arrest 
(Bilim, 2000). The cell cycle analysis with Propidium iodide (PI) staining of propolis 
treated cells showed that the cells enter cell cycle arrest in G2/M phase. When the 
results were compared, increase in the propolis treated cells’ G2/M arrest was not 
as dramatic as Adriamycin effect. Therefore we can conclude that propolis slightly 
increases the number of cells stuck in the G2/M phase. 
Previously CAPE was showed as an inhibitor of invasion in hepatocellular carcinoma 
(Jin, 2005). We used scratch assay to see the effect of propolis on breast cancer 
cells. Scratch assay was an easy but informative assay to analyze the effect of 
propolis on invasion property of breast cancer cells. For this experiment one of the 
most invasive breast cancer cell, MDA-MB-231 was chosen. When treated with 
higher concentrations of propolis, cells could not invade the scratched area while 
DMSO treated cells could fill up the scratched area within 2 days. Since we dropped 
the serum concentration in the growth media, we can say that invasion of the 
control samples are not due to the reproduction of existing cells but the invasion of 
the neighboring cells. This assay is a strong evidence to show the ability of propolis 
to block the invasion on breast carcinoma cell lines. 
In conclusion, propolis showed a cytotoxic effect on breast carcinoma cell lines by 
inducing apoptosis, G2/M arrest as well as delaying the invasion capacity of the cells 
which makes it a potent anti-tumorigenic compound that may be useful in cancer 
chemoprevention or therapy. 
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6 Future Perspectives 
 
We are interested in the effects of propolis on cell growth in human cancer cells, as 
predictors of novel agents that may be useful in cancer chemoprevention or 
therapy. Anti-proliferative activity of DMSO and water extracts of Turkish propolis 
was previously demonstrated with prostate cancer cell lines (Barlak, 2011). In this 
study, we showed that DMSO extracts of Turkish propolis has an anti-proliferative 
activity on breast carcinoma cell lines. Effects of Turkish propolis can be 
investigated in other cancer types such as hepatocellular carcinoma and lung 
carcinoma which we have preliminary data that shows cytotoxic effect.  
Propolis and its polyphenols target TRAIL-induced apoptosis signaling pathway in 
tumor cells and sensitizes the TRAIL-resistant cancer cells (Szliszka, 2013). 
Therefore, more comprehensive study on apoptosis pathway that propolis induce 
can be designed to reveal the molecular mechanism behind the cytotoxic effect of 
propolis on carcinoma cells. We showed that DMSO extracts of Turkish propolis 
increase the apoptosis rate in breast carcinoma cells however the responsible 
apoptosis pathway is yet to be unknown. The activity of caspases (caspase3 and 7) 
and other apoptotic molecules on propolis treated carcinoma cells is required to be 
analyzed.  
To eliminate the necrosis as a cell death another PARP-1 western blot analysis can 
be done with a different antibody which can recognize the 50 kDa fragment of 
PARP-1 protein which is associated with necrosis (Buontempo, 2010). To eliminate 
the senescence as a cell death, senescence β-Galactosidase staining can be 
performed to propolis treated cells. 
Due to the technical problems, we performed the cell cycle analysis of only one cell 
line (MDA-MB-231). The following experiments are required to analyze the effects 
of propolis on cell cycle with remaining breast carcinoma cell lines. Flow cytometer 
can be used for both PI staining which is used for cell cycle analysis and Annexin-V 
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staining for apoptosis detection. Therefore, Annexin-V staining can be performed to 
confirm the apoptotic cell death of propolis treated cell lines. 
To confirm the scratch assay results, matrigel assay can be performed so that 
prevention of invasion can be proved. In addition, epithelial to mesenchymal 
transition (EMT) markers (vimentin as mesenchymal and E-cadherin as an epithelial 
marker) can be detected with immunofluorescence method to analyze the effect of 
propolis on EMT. 
Anti-proliferative activities of CAPE and Chrysin are not always based on similar 
mechanisms as whole propolis extract was revealed by Sawicka et. al. in 2012. 
Therefore, chemical analysis of propolis compound can be performed and the active 
components of the propolis extract can be studied separately or in combinations to 
see the individual effects of chemicals in propolis. We also believe in the synergistic 
effects of individual compounds, depending on their concentrations. For example, 
CAPE is an effective adjuvant by targeting Akt signaling in advanced prostate cancer. 
CAPE treatment reduces the dosage of chemotherapeutic agents required therefore 
it can be used as a potential adjuvant therapy since it is a safe, natural product (Liu, 
2013). The resulting active components of Turkish propolis can be investigated in 
synergistic effects with existing chemotherapeutic agents.  
Protective role of flavonoids in propolis were demonstrated on rats to reduce the 
toxicity as an adjuvant to chemotherapeutic agents (Padmavathi, 2006). According 
to this study, there are strong evidences for propolis being a cytotoxic material so 
that animal cancer models can be treated with Turkish propolis to see the effects on 
healing. Clinical studies to substantiate these results can help to show the beneficial 
effects of Turkish propolis since little information is available concerning propolis 
efficiency clinically. Pharmacological variability of preparations is expected, but 
biological properties of propolis could be linked to its chemical composition and to 
its botanical sources (Sforcin, 2011). If Turkish propolis is standardized based on 
most important active constituents, it can be subjected to clinical trials.  
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8 Appendix 
 
8.1 IC50 Analysis of Propolis 
 
 
Table 8.1: The ELISA reading results of MCF10A cell numbers when treated with 
Propolis-1 and DMSO. Percent cell death and IC50 value were calculated according 
to this data.  
MCF10A Concentration (ug/ml)   
Propolis-1 100 50 25 12.5 6.125   
Set 1 0.003 0.448 1.161 1.692 1.415   
Set 2 -0.002 1.018 1.859 2.192 1.729   
Set 3 0.019 0.751 1.687 2.302 2.282   
AVERAGE 0.007 0.739 1.569 2.062 1.809   
SEM 0.006 0.165 0.21 0.188 0.253   
  
     
  
MCF10A Concentration (ug/ml)   
DMSO 100 50 25 12.5 6.125   
Set 1 0.858 1.288 1.505 1.824 1.812   
Set 2 0.904 1.367 1.672 1.829 1.925   
Set 3 0.757 1.388 1.789 2.184 1.801   
AVERAGE 0.84 1.348 1.655 1.946 1.846   
SEM 0.043 0.03 0.082 0.119 0.04   
  
     
  
Percent Cell 
Death 
Concentration (ug/ml)   
100 50 25 12.5 6.125   
Set 1 99.65 65.217 22.857 7.237 21.909   
Set 2 100.221 25.53 -11.184 -19.847 10.182   
Set 3 97.49 45.893 5.702 -5.403 -26.707   
AVERAGE 99.167 45.178 5.196 -5.961 2.004   
SEM 0.679 9.356 8.025 6.388 11.96   
  
     
  
y-int -83.773           
slope 35.115   IC50 45 ug/ml   
R2 0.78           
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Table 8.2: The ELISA reading results of MCF10A cell numbers when treated with 
Propolis-2 and DMSO. Percent cell death and IC50 value were calculated according 
to this data.  
MCF10A Concentration (ug/ml)   
Propolis-2 200 150 100 75 37.5   
Set 1 0.103 0.109 0.246 0.327 0.406   
Set 2 0.147 0.197 0.492 0.687 0.747   
Set 3 0.101 0.169 0.376 0.418 0.653   
AVERAGE 0.117 0.158 0.371 0.477 0.602   
SEM 0.015 0.026 0.071 0.108 0.102   
  
     
  
MCF10A Concentration (ug/ml)   
DMSO 200 150 100 75 37.5   
Set 1 0.329 0.584 0.786 0.959 0.923   
Set 2 0.349 0.766 1.16 0.913 1.075   
Set 3 0.397 0.47 0.913 0.91 0.713   
AVERAGE 0.358 0.607 0.953 0.927 0.904   
SEM 0.02 0.086 0.11 0.016 0.105   
  
     
  
Percent Cell 
Death 
Concentration (ug/ml)   
200 150 100 75 37.5   
Set 1 68.693 81.336 68.702 65.902 56.013   
Set 2 57.88 74.282 57.586 24.754 30.512   
Set 3 74.559 64.043 58.817 54.066 8.415   
AVERAGE 67.318 73.97 61.07 48.544 33.407   
SEM 3.989 4.105 2.878 9.986 11.24   
  
     
  
y-int -50.593           
slope 23.507   IC50 72 ug/ml   
R2 0.9           
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Table 8.3: The ELISA reading results of MCF12A cell numbers when treated with 
Propolis-1 and DMSO. Percent cell death and IC50 value were calculated according 
to this data.  
MCF12A Concentration (ug/ml) 
Propolis-1 100 80 50 40 25 12.5 
Set 1 0.006 0.034 0.203 0.022 0.073 0.529 
Set 2 0.096 0.19 0.526 0.298 0.373 0.641 
Set 3 0.021 0.189 0.332 0.466 0.615 0.707 
Set 4 0.012 0.149 0.478 0.308 0.743 0.707 
AVERAGE 0.034 0.141 0.385 0.274 0.451 0.646 
SEM 0.021 0.037 0.073 0.092 0.148 0.042 
  
     
  
MCF12A Concentration (ug/ml) 
DMSO 100 80 50 40 25 12.5 
Set 1 0.404 0.807 0.326 0.922 0.725 0.394 
Set 2 0.661 0.851 0.64 0.836 0.927 0.88 
Set 3 0.313 0.67 0.724 0.741 0.806 0.905 
Set 4 0.322 0.4 0.815 0.58 0.682 0.935 
AVERAGE 0.425 0.682 0.626 0.77 0.785 0.779 
SEM 0.081 0.102 0.106 0.073 0.054 0.129 
  
     
  
Percent Cell 
Death 
Concentration (ug/ml) 
100 80 50 40 25 12.5 
Set 1 98.515 95.787 37.73 97.614 89.931 -34.264 
Set 2 85.477 77.673 17.813 64.354 59.763 27.159 
Set 3 93.291 71.791 54.144 37.112 23.697 21.878 
Set 4 96.273 62.75 41.35 46.897 -8.944 24.385 
AVERAGE 92 79.326 38.498 64.416 42.548 17.073 
SEM 2.484 6.062 6.517 11.53 18.611 12.855 
  
     
  
y-int -67.185           
slope 33   IC50 35 ug/ml   
R2 0.82           
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Table 8.4: The ELISA reading results of MCF12A cell numbers when treated with 
Propolis-2 and DMSO. Percent cell death and IC50 value were calculated according 
to this data.  
MCF12A Concentration (ug/ml) 
Propolis-2 37.5 50 75 100 150 200 
Set 1 0.06 0.068 0.05 0.058 0.027 0.007 
Set 2 0.174 0.235 0.144 0.107 0.044 0.038 
Set 3 0.265 0.288 0.263 0.183 0.069 0.049 
Set 4 0.285 0.304 0.216 0.155 0.089 0.049 
AVERAGE 0.196 0.224 0.168 0.126 0.057 0.036 
SEM 0.051 0.054 0.046 0.027 0.014 0.01 
  
     
  
MCF12A Concentration (ug/ml) 
DMSO 37.5 50 75 100 150 200 
Set 1 0.173 0.169 0.193 0.193 0.143 0.113 
Set 2 0.413 0.338 0.367 0.268 0.319 0.115 
Set 3 0.45 0.466 0.412 0.339 0.487 0.168 
Set 4 0.554 0.601 0.771 0.921 0.489 0.179 
AVERAGE 0.398 0.394 0.436 0.43 0.36 0.144 
SEM 0.081 0.092 0.121 0.166 0.082 0.017 
  
     
  
Percent Cell 
Death 
Concentration (ug/ml) 
37.5 50 75 100 150 200 
Set 1 65.318 59.763 74.093 69.948 81.119 93.805 
Set 2 57.869 30.473 60.763 60.075 86.207 66.957 
Set 3 41.111 38.197 36.165 46.018 85.832 70.833 
Set 4 48.556 49.418 71.984 83.17 81.8 72.626 
AVERAGE 50.754 43.147 61.468 70.698 84.167 75 
SEM 4.618 5.562 7.538 6.923 1.152 5.231 
  
     
  
y-int -32.074           
slope 21.581   IC50 45 ug/ml   
R2 0.8           
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Table 8.5: The ELISA reading results of MDA-MB-231 cell numbers when treated 
with Propolis-1 and DMSO. Percent cell death and IC50 value were calculated 
according to this data.  
MDA-MB-231 Concentration (ug/ml) 
Propolis-1 100 75 50 25 12.5 6 
Set 1 -0.006 -0.006 0.267 0.358 0.465 0.61 
Set 2 -0.004 -0.013 0.222 0.41 0.559 0.449 
Set 3 -0.005 -0.006 0.216 0.424 0.692 0.764 
Set 4 -0.014 -0.001 0.283 0.409 0.651 0.692 
AVERAGE -0.007 -0.007 0.247 0.4 0.592 0.629 
SEM 0.002 0.002 0.017 0.014 0.051 0.068 
  
     
  
MDA-MB-231 Concentration (ug/ml) 
DMSO 100 75 50 25 12.5 6 
Set 1 0.616 0.527 0.714 0.663 0.966 0.801 
Set 2 0.694 0.68 0.703 0.637 0.746 0.888 
Set 3 0.574 0.499 0.625 0.608 0.664 0.61 
Set 4 0.481 0.565 0.549 0.539 0.495 0.544 
AVERAGE 0.591 0.568 0.648 0.612 0.718 0.711 
SEM 0.044 0.04 0.038 0.027 0.098 0.08 
  
     
  
Percent Cell 
Death 
Concentration (ug/ml) 
100 75 50 25 12.5 6 
Set 1 100.974 101.139 62.605 46.003 51.863 23.845 
Set 2 100.576 101.912 68.421 35.636 25.067 49.437 
Set 3 100.871 101.202 65.44 30.263 -4.217 -25.246 
Set 4 102.911 100.177 48.452 24.119 -31.515 -27.206 
AVERAGE 101.184 101.232 61.883 34.641 17.549 11.533 
SEM 0.463 0.31 3.832 4.021 15.706 16.42 
  
     
  
y-int -64.179           
slope 35.005   IC50 26 ug/ml   
R2 0.91           
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Table 8.6: The ELISA reading results of MDA-MB-231 cell numbers when treated 
with Propolis-2 and DMSO. Percent cell death and IC50 value were calculated 
according to this data.  
 
MDA-MB-
231 
Concentration (ug/ml) 
Propolis-2 150 120 75 60 37.5 30 
Set 1 0.001 0.012 0.018 0.036 0.054 0.052 
Set 2 0.017 0.039 0.144 0.073 0.139 0.149 
Set 3 0.007 0.028 0.152 0.11 0.125 0.134 
Set 4 0 0.052 0.127 0.135 0.108 0.122 
AVERAGE 0.006 0.033 0.11 0.089 0.107 0.114 
SEM 0.004 0.008 0.031 0.022 0.019 0.021 
  
     
  
MDA-MB-
231 
Concentration (ug/ml) 
DMSO 150 120 75 60 37.5 30 
Set 1 0.014 0.118 0.201 0.211 0.193 0.223 
Set 2 0.026 0.142 0.187 0.187 0.138 0.147 
Set 3 0.083 0.107 0.142 0.128 0.073 0.141 
Set 4 0.07 0.125 0.099 0.117 0.086 0.12 
AVERAGE 0.048 0.123 0.157 0.161 0.123 0.158 
SEM 0.017 0.007 0.023 0.023 0.027 0.023 
  
     
  
Percent Cell 
Death 
Concentration (ug/ml) 
150 120 75 60 37.5 30 
Set 1 92.857 89.831 91.045 82.938 72.021 76.682 
Set 2 34.615 72.535 22.995 60.963 -0.725 -1.361 
Set 3 91.566 73.832 -7.042 14.063 -71.233 4.965 
Set 4 100 58.4 -28.283 -15.385 -25.581 -1.667 
AVERAGE 87.5 73.171 29.936 44.72 13.008 27.848 
SEM 13.244 5.567 22.642 19.386 26.284 16.617 
  
     
  
y-int -125.33           
slope 40.743   IC50 74 ug/ml   
R2 0.8           
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Table 8.7: The ELISA reading results of CAMA-1 cell numbers when treated with 
Propolis-1 and DMSO. Percent cell death and IC50 value were calculated according 
to this data.  
CAMA-1   Concentration (ug/ml) 
Propolis-1 80 60 50 40 30 25 
Set 1 0 0 0 0.034 0.058 0.063 
Set 2 0 0 0.019 0.067 0.069 0.083 
Set 3 0.007 0.001 0.02 0.073 0.091 0.113 
Set 4 -0.002 0.001 0.007 0.071 0.091 0.114 
AVERAGE 0.001 0.001 0.012 0.061 0.077 0.093 
SEM 0.002 0 0.005 0.009 0.008 0.012 
  
     
  
CAMA-1   Concentration (ug/ml) 
DMSO 80 60 50 40 30 25 
Set 1 0.087 0.157 0.196 0.191 0.201 0.202 
Set 2 0.202 0.187 0.198 0.18 0.207 0.184 
Set 3 0.22 0.158 0.21 0.182 0.183 0.177 
Set 4 0.158 0.129 0.19 0.164 0.198 0.138 
AVERAGE 0.167 0.158 0.199 0.179 0.197 0.175 
SEM 0.03 0.012 0.004 0.006 0.005 0.013 
  
     
  
Percent Cell 
Death 
Concentration (ug/ml) 
80 60 50 40 30 25 
Set 1 100 100 100 82.199 71.144 68.812 
Set 2 100 100 90.404 62.778 66.667 54.891 
Set 3 96.818 99.367 90.476 59.89 50.273 36.158 
Set 4 101.266 99.225 96.316 56.707 54.04 17.391 
AVERAGE 99.401 99.367 93.97 65.922 60.914 46.857 
SEM 0.822 0.189 2.038 4.97 4.314 9.71 
  
     
  
y-int -109.394           
slope 49.468   IC50 25 ug/ml   
R2 0.9           
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Table 8.8: The ELISA reading results of CAMA-1cell numbers when treated with 
Propolis-2 and DMSO. Percent cell death and IC50 value were calculated according 
to this data.  
CAMA-1 Concentration (ug/ml) 
Propolis-2 100 80 50 40 25 20 
Set 1 0.022 0.025 0.072 0.078 0.101 0.109 
Set 2 0.013 0.028 0.056 0.063 0.097 0.054 
Set 3 0.016 0.013 0.054 0.101 0.039 0.054 
Set 4 0.017 0.032 0.15 0.123 0.139 0.12 
AVERAGE 0.017 0.025 0.083 0.091 0.094 0.084 
SEM 0.002 0.004 0.023 0.013 0.021 0.018 
  
     
  
CAMA-1 Concentration (ug/ml) 
DMSO 100 80 50 40 25 20 
Set 1 0.173 0.077 0.292 0.177 0.19 0.108 
Set 2 0.156 0.202 0.294 0.249 0.116 0.1 
Set 3 0.122 0.203 0.155 0.189 0.131 0.122 
Set 4 0.127 0.207 0.208 0.148 0.154 0.158 
AVERAGE 0.145 0.172 0.237 0.191 0.148 0.122 
SEM 0.012 0.032 0.034 0.021 0.016 0.013 
  
     
  
Percent Cell 
Death 
Concentration (ug/ml) 
100 80 50 40 25 20 
Set 1 87.283 67.532 75.342 55.932 46.842 -0.926 
Set 2 91.667 86.139 80.952 74.699 16.379 46 
Set 3 86.885 93.596 65.161 46.561 70.229 55.738 
Set 4 86.614 84.541 27.885 16.892 9.74 24.051 
AVERAGE 88.276 85.465 64.979 52.356 36.486 31.148 
SEM 1.034 4.801 10.357 10.477 12.155 10.91 
  
     
  
y-int -84.629           
slope 37.999   IC50 35 ug/ml   
R2 0.99           
 
 
 
124 
 
Table 8.9: The ELISA reading results of MDA-MB-453 cell numbers when treated 
with Propolis-1 and DMSO. Percent cell death and IC50 value were calculated 
according to this data.  
MDA-MB-453 Concentration (ug/ml)   
Propolis-1 80 60 40 30 20   
Set 1 0.001 0.046 0.041 0.043 0.034   
Set 2 0.003 0.027 0.073 0.085 0.197   
Set 3 0.052 0.024 0.077 0.086 0.129   
Set 4 0.036 0.016 0.045 0.185 0.134   
AVERAGE 0.023 0.028 0.059 0.1 0.124   
SEM 0.013 0.006 0.009 0.03 0.034   
  
     
  
MDA-MB-453 Concentration (ug/ml)   
DMSO 80 60 40 30 20   
Set 1 0.119 0.093 0.168 0.078 0.144   
Set 2 0.115 0.13 0.106 0.141 0.086   
Set 3 0.059 0.199 0.052 0.151 0.065   
AVERAGE 0.098 0.141 0.109 0.123 0.098   
SEM 0.019 0.031 0.034 0.023 0.024   
  
     
  
Percent Cell 
Death 
Concentration (ug/ml)   
80 60 40 30 20   
Set 1 97.391 79.231 31.132 39.716 -129.07   
Set 2 11.864 87.94 -48.077 43.046 -98.462   
Set 3 38.983 91.96 13.462 -22.517 -106.154   
AVERAGE 76.531 80.142 45.872 18.699 -26.531   
SEM 22.041 3.556 23.844 17.413 25.576   
  
     
  
y-int -250.482           
slope 77.961   IC50 47 ug/ml   
R2 0.93           
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Table 8.10: The ELISA reading results of MDA-MB-453 cell numbers when treated 
with Propolis-2 and DMSO. Percent cell death and IC50 value were calculated 
according to this data.  
MDA-MB-
453 
Concentration (ug/ml) 
  
Propolis-2 30 50 60 100 120   
Set 1 0.045 0.042 0.045 0.018 0.014   
Set 2 0.108 0.093 0.095 0.06 0.027   
Set 3 0.118 0.079 0.073 0.053 0.027   
Set 4 0.093 0.073 0.101 0.058 0.028   
AVERAGE 0.091 0.072 0.079 0.047 0.024   
SEM 0.016 0.011 0.013 0.01 0.003   
  
     
  
MDA-MB-
453 
Concentration (ug/ml) 
  
DMSO 30 50 60 100 120   
Set 1 0.128 0.052 0.179 0.222 0.071   
Set 2 0.186 0.134 0.213 0.205 0.092   
Set 3 0.125 0.185 0.176 0.214 0.077   
Set 4 0.115 0.191 0.082 0.086 0.047   
AVERAGE 0.139 0.141 0.163 0.182 0.072   
SEM 0.016 0.032 0.028 0.032 0.009   
  
     
  
Percent Cell 
Death 
Concentration (ug/ml)   
30 50 60 100 120   
Set 1 64.844 19.231 74.86 91.892 80.282   
Set 2 41.935 30.597 55.399 70.732 70.652   
Set 3 5.6 57.297 58.523 75.234 64.935   
Set 4 19.13 61.78 -23.171 32.558 40.426   
AVERAGE 34.532 48.936 51.534 74.176 66.667   
SEM 11.289 9.047 19.138 10.956 7.38   
  
     
  
y-int -56.529           
slope 26.85   IC50 53 ug/ml   
R2 0.92           
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Table 8.11: The ELISA reading results of MDA-MB-468 cell numbers when treated 
with Propolis-1 and DMSO. Percent cell death and IC50 value were calculated 
according to this data.  
MDA-MB-468 Concentration (ug/ml) 
Propolis-1 15 20 30 40 60 80 
Set 1 0.268 0.199 0.048 0.033 0.017 0.004 
Set 2 0.331 0.053 0.233 0.172 0.032 -0.003 
Set 3 0.335 0.292 0.301 0.204 0.076 -0.004 
Set 4 0.325 0.293 0.233 0.244 0.142 0.009 
AVERAGE 0.315 0.209 0.204 0.163 0.067 0.002 
SEM 0.016 0.057 0.054 0.046 0.028 0.003 
  
     
  
MDA-MB-468 Concentration (ug/ml) 
DMSO 15 20 30 40 60 80 
Set 1 0.492 0.433 0.466 0.186 0.146 0.264 
Set 2 0.373 0.362 0.423 0.372 0.342 0.212 
Set 3 0.272 0.344 0.395 0.388 0.372 0.196 
Set 4 0.375 0.263 0.25 0.555 0.606 0.045 
AVERAGE 0.378 0.351 0.384 0.375 0.367 0.179 
SEM 0.045 0.035 0.047 0.075 0.094 0.047 
  
     
  
Percent Cell 
Death 
Concentration (ug/ml) 
15 20 30 40 60 80 
Set 1 45.528 54.042 89.7 82.258 88.356 98.485 
Set 2 11.26 85.359 44.917 53.763 90.643 101.415 
Set 3 -23.162 15.116 23.797 47.423 79.57 102.041 
Set 4 13.333 -11.407 6.8 56.036 76.568 80 
AVERAGE 16.667 40.456 46.875 56.533 81.744 98.883 
SEM 12.201 18.478 15.567 6.694 2.97 4.584 
  
     
  
y-int -104.079           
slope 45.398   IC50 30 ug/ml   
R2 0.97           
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Table 8.12: The ELISA reading results of MDA-MB-468 cell numbers when treated 
with Propolis-2 and DMSO. Percent cell death and IC50 value were calculated 
according to this data.  
MDA-MB-
468 
Concentration (ug/ml) 
Propolis-2 25 30 50 60 100 120 
Set 1 0.119 0.075 0.036 0.06 0.01 0.014 
Set 2 0.546 0.435 0.195 0.234 0.008 0.014 
Set 3 0.447 0.35 0.188 0.236 0.048 0.004 
Set 4 0.457 0.379 0.19 0.201 0.035 0.02 
AVERAGE 0.392 0.31 0.152 0.183 0.025 0.013 
SEM 0.094 0.08 0.039 0.042 0.01 0.003 
  
     
  
MDA-MB-
468 
Concentration (ug/ml) 
DMSO 25 30 50 60 100 120 
Set 1 0.301 0.234 0.891 0.873 0.931 0.09 
Set 2 0.793 0.619 0.773 1.123 0.798 0.303 
Set 3 0.83 0.859 0.606 0.985 0.606 0.425 
Set 4 0.927 1.004 0.247 0.428 0.403 0.253 
AVERAGE 0.713 0.679 0.629 0.852 0.685 0.268 
SEM 0.14 0.168 0.14 0.15 0.115 0.069 
  
     
  
Percent Cell 
Death 
Concentration (ug/ml) 
25 30 50 60 100 120 
Set 1 60.465 67.949 95.96 93.127 98.926 84.444 
Set 2 31.148 29.725 74.774 79.163 98.997 95.38 
Set 3 46.145 59.255 68.977 76.041 92.079 99.059 
Set 4 50.701 62.251 23.077 53.037 91.315 92.095 
AVERAGE 45.021 54.345 75.835 78.521 96.35 95.149 
SEM 5.306 7.404 13.481 7.233 1.835 2.747 
  
     
  
y-int -57.459           
slope 32.889   IC50 26 ug/ml   
R2 0.97           
 
 
 
128 
 
Table 8.13: The ELISA reading results of T47D  cell numbers when treated with 
Propolis-1 and DMSO. Percent cell death and IC50 value were calculated according 
to this data.  
T47D Concentration (ug/ml) 
Propolis-1 120 100 60 50 30 25 
Set 1 0.045 0.064 0.039 0.097 0.365 0.563 
Set 2 0.032 0.006 0.39 0.749 1.636 1.658 
Set 3 0.035 0.025 0.758 0.946 1.697 2.067 
Set 4 0.031 0.031 0.99 0.931 1.955 2.009 
AVERAGE 0.036 0.032 0.544 0.681 1.413 1.574 
SEM 0.003 0.012 0.209 0.2 0.356 0.349 
  
     
  
T47D Concentration (ug/ml) 
DMSO 120 100 60 50 30 25 
Set 1 1.152 2.009 2.511 2.554 2.452 2.159 
Set 2 1.461 2.105 2.543 2.458 2.518 2.548 
Set 3 1.466 1.679 2.233 2.137 2.668 2.483 
Set 4 0.263 1.498 1.15 1.728 1.975 2.099 
AVERAGE 1.086 1.823 2.109 2.219 2.403 2.322 
SEM 0.284 0.142 0.327 0.186 0.15 0.113 
  
     
  
Percent Cell 
Death 
Concentration (ug/ml) 
120 100 60 50 30 25 
Set 1 96.094 96.814 98.447 96.202 85.114 73.923 
Set 2 97.81 99.715 84.664 69.528 35.028 34.929 
Set 3 97.613 98.511 66.055 55.732 36.394 16.754 
Set 4 88.213 97.931 13.913 46.123 1.013 4.288 
AVERAGE 96.685 98.245 74.206 69.311 41.199 32.214 
SEM 2.007 0.523 16.146 9.443 14.988 13.147 
  
     
  
y-int -104.651           
slope 43.289   IC50 36 ug/ml   
R2 0.98           
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Table 8.14: The ELISA reading results of T47D  cell numbers when treated with 
Propolis-2 and DMSO. Percent cell death and IC50 value were calculated according 
to this data.  
T47D Concentration (ug/ml) 
Propolis-2 120 100 60 50 30 25 
Set 1 0.12 0.134 0.203 0.283 1.062 0.64 
Set 2 0.06 0.252 0.391 1.502 1.724 1.616 
Set 3 0.126 0.07 1.041 1.547 1.847 1.715 
Set 4 0.085 0.069 0.585 1.05 1.935 2.164 
AVERAGE 0.098 0.131 0.555 1.096 1.642 1.534 
SEM 0.015 0.043 0.18 0.293 0.198 0.321 
  
     
  
T47D Concentration (ug/ml) 
DMSO 120 100 60 50 30 25 
Set 1 0.737 1.419 2.105 2.503 2.482 2.273 
Set 2 1.022 2.07 1.999 2.324 2.352 2.298 
Set 3 1.424 2.336 1.978 2.582 2.374 1.981 
Set 4 1.357 1.269 1.967 2.186 1.823 2.216 
AVERAGE 1.135 1.774 2.012 2.399 2.258 2.192 
SEM 0.159 0.256 0.032 0.089 0.148 0.072 
  
     
  
Percent Cell 
Death 
Concentration (ug/ml) 
120 100 60 50 30 25 
Set 1 83.718 90.557 90.356 88.694 57.212 71.843 
Set 2 94.129 87.826 80.44 35.37 26.701 29.678 
Set 3 91.152 97.003 47.371 40.085 22.199 13.428 
Set 4 93.736 94.563 70.259 51.967 -6.144 2.347 
AVERAGE 91.366 92.616 72.416 54.314 27.281 30.018 
SEM 2.096 1.771 7.976 10.454 11.243 13.202 
  
     
  
y-int -119.562           
slope 45.188   IC50 43 ug/ml   
R2 0.96           
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Table 8.15: The ELISA reading results of MCF7 cell numbers when treated with 
Propolis-1 and DMSO. Percent cell death and IC50 value were calculated according 
to this data.  
MCF7 Concentration (ug/ml) 
Propolis-1 100 80 50 40 25 20 
Set 1 0.025 0.11 0.259 0.335 0.298 0.975 
Set 2 0.056 0.154 0.533 1.137 1.659 1.637 
Set 3 0.077 0.253 0.619 1.166 1.525 1.223 
Set 4 0.063 0.166 0.502 1.044 1.334 1.338 
AVERAGE 0.055 0.171 0.478 0.921 1.204 1.293 
SEM 0.011 0.03 0.077 0.197 0.309 0.137 
  
     
  
 MCF7 Concentration (ug/ml) 
DMSO 100 80 50 40 25 20 
Set 1 0.498 1.404 1.708 1.753 1.697 1.517 
Set 2 0.634 1.742 1.757 1.767 1.719 1.562 
Set 3 1.067 1.543 1.709 1.61 1.533 1.573 
Set 4 1.078 0.901 1.225 1.132 1.248 1.106 
AVERAGE 0.819 1.398 1.6 1.566 1.549 1.44 
SEM 0.149 0.179 0.125 0.149 0.109 0.112 
  
     
  
Percent Cell 
Death 
Concentration (ug/ml) 
100 80 50 40 25 20 
Set 1 94.98 92.165 84.836 80.89 82.44 35.728 
Set 2 91.167 91.16 69.664 35.654 3.49 -4.802 
Set 3 92.784 83.603 63.78 27.578 0.522 22.25 
Set 4 94.156 81.576 59.02 7.774 -6.891 -20.976 
AVERAGE 93.284 87.768 70.125 41.188 22.272 10.208 
SEM 0.723 2.308 4.862 13.406 18.163 11.122 
  
     
  
y-int -151.771           
slope 54.181   IC50 41 ug/ml   
R2 0.97           
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Table 8.16: The ELISA reading results of MCF7 cell numbers when treated with 
Propolis-2 and DMSO. Percent cell death and IC50 value were calculated according 
to this data.  
MCF7  Concentration (ug/ml) 
Propolis-2 120 100 60 50 30 25 
Set 1 0.116 0.123 0.332 0.259 1.878 0.724 
Set 2 0.053 0.099 0.351 1.036 1.735 2.044 
Set 3 0.087 0.178 0.624 1.355 0.602 2.06 
Set 4 0.099 0.15 0.71 1.358 0.7 0.397 
AVERAGE 0.089 0.138 0.504 1.002 1.807 1.609 
SEM 0.013 0.017 0.096 0.259 0.051 0.383 
  
     
  
MCF7  Concentration (ug/ml) 
DMSO 120 100 60 50 30 25 
Set 1 0.907 1.16 2.113 2.175 2.09 2.049 
Set 2 0.615 1.312 1.887 2.293 1.917 2.039 
Set 3 0.741 0.952 1.613 1.853 0.996 1.41 
Set 4 1.071 1.488 0.637 1.144 0.922 0.909 
AVERAGE 0.834 1.228 1.563 1.866 1.481 1.602 
SEM 0.099 0.114 0.325 0.258 0.304 0.275 
  
     
  
Percent Cell 
Death 
Concentration (ug/ml) 
120 100 60 50 30 25 
Set 1 87.211 89.397 84.288 88.092 10.144 64.666 
Set 2 91.382 92.454 81.399 54.819 9.494 -0.245 
Set 3 88.259 81.303 61.314 26.875 39.558 -46.099 
Set 4 90.756 89.919 -11.46 -18.706 24.078 56.326 
AVERAGE 89.329 88.762 67.754 46.302 -22.012 -0.437 
SEM 0.861 2.095 19.622 19.668 11.379 22.883 
  
     
  
y-int -270.841           
slope 78.093   IC50 61 ug/ml   
R2 0.89           
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Table 8.17: The ELISA reading results of HCC-1937 cell numbers when treated with 
Propolis-1 and DMSO. Percent cell death and IC50 value were calculated according 
to this data.  
HCC-1937  Concentration (ug/ml) 
Propolis-1 30 37.5 60 75 120 150 
Set 1 0.63 0.69 0.552 0.555 0.433 0.443 
Set 2 0.631 0.559 0.516 0.437 0.417 0.332 
Set 3 0.427 0.52 0.387 0.463 0.099 0.291 
Set 4 0.629 0.504 0.492 0.397 0.403 0.276 
AVERAGE 0.579 0.568 0.487 0.463 0.338 0.336 
SEM 0.051 0.042 0.035 0.034 0.08 0.038 
  
     
  
HCC-1937  Concentration (ug/ml) 
DMSO 30 37.5 60 75 120 150 
Set 1 0.807 0.864 0.827 0.806 0.775 0.68 
Set 2 0.775 0.86 0.81 0.81 0.732 0.704 
Set 3 0.746 0.788 0.758 0.738 0.707 0.627 
Set 4 0.833 0.772 0.745 0.771 0.713 0.689 
AVERAGE 0.79 0.821 0.785 0.781 0.732 0.675 
SEM 0.019 0.024 0.02 0.017 0.015 0.017 
  
     
  
Percent Cell 
Death 
Concentration (ug/ml) 
30 37.5 60 75 120 150 
Set 1 21.933 20.139 33.253 31.141 44.129 34.853 
Set 2 18.581 35 36.296 46.049 43.033 52.841 
Set 3 42.761 34.01 48.945 37.263 85.997 53.589 
Set 4 24.49 34.715 33.96 48.508 43.478 59.942 
AVERAGE 26.709 30.816 37.962 40.717 53.825 50.222 
SEM 4.686 3.131 3.177 3.471 9.193 4.669 
  
     
  
y-int -28.656           
slope 16.334   IC50 123 ug/ml   
R2 0.95           
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Table 8.18: The ELISA reading results of HCC-1937 cell numbers when treated with 
Propolis-2 and DMSO. Percent cell death and IC50 value were calculated according 
to this data.  
HCC-1937 Concentration (ug/ml)   
Propolis-2 150 120 75 60 30   
Set 1 0.01 0.06 0.104 0.096 0.172   
Set 2 0.022 0.169 0.324 0.445 0.781   
Set 3 0.037 0.204 0.437 0.482 0.778   
Set 4 0.052 0.245 0.319 0.563 0.588   
AVERAGE 0.03 0.17 0.296 0.397 0.58   
SEM 0.009 0.04 0.07 0.103 0.143   
  
     
  
HCC-1937 Concentration (ug/ml)   
DMSO 150 120 75 60 30   
Set 1 0.09 0.419 0.457 0.238 0.626   
Set 2 0.129 0.43 0.515 0.39 0.601   
Set 3 0.098 0.231 0.313 0.475 0.55   
Set 4 0.147 0.187 0.223 0.505 0.361   
AVERAGE 0.116 0.317 0.377 0.402 0.535   
SEM 0.013 0.063 0.067 0.06 0.06   
  
     
  
Percent Cell 
Death 
Concentration (ug/ml)   
150 120 75 60 30   
Set 1 88.889 85.68 77.243 59.664 72.524   
Set 2 82.946 60.698 37.087 -14.103 -29.95   
Set 3 62.245 11.688 -39.617 -1.474 -41.455   
Set 4 64.626 -31.016 -43.049 -11.485 -62.881   
AVERAGE 74.138 46.372 21.485 1.244 -8.411   
SEM 5.735 22.72 25.813 15.135 26.119   
  
     
  
y-int -190.347           
slope 50.278   IC50 119 ug/ml   
R2 0.88           
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Table 8.19: The ELISA reading results of MDA-MB-157 cell numbers when treated 
with Propolis-1 and DMSO. Percent cell death and IC50 value were calculated 
according to this data.  
MDA-MB-157 Concentration (ug/ml) 
Propolis-1 120 100 60 50 30 25 
Set 1 0.179 0.105 0.267 0.307 0.376 0.386 
Set 2 0.232 0.161 0.215 0.497 0.474 0.689 
Set 3 0.211 0.195 0.263 0.446 0.48 0.585 
Set 4 0.233 0.158 0.299 0.175 0.484 0.369 
AVERAGE 0.214 0.155 0.261 0.356 0.454 0.507 
SEM 0.013 0.019 0.017 0.073 0.026 0.078 
  
     
  
MDA-MB-157 Concentration (ug/ml) 
DMSO 120 100 60 50 30 25 
Set 1 0.421 0.478 0.477 0.483 0.41 0.536 
Set 2 0.459 0.46 0.454 0.465 0.484 0.426 
Set 3 0.403 0.445 0.478 0.5 0.503 0.506 
Set 4 0.413 0.413 0.421 0.439 0.413 0.427 
AVERAGE 0.424 0.449 0.458 0.472 0.453 0.474 
SEM 0.012 0.014 0.013 0.013 0.024 0.028 
  
     
  
Percent Cell 
Death 
Concentration (ug/ml) 
120 100 60 50 30 25 
Set 1 57.482 78.033 44.025 36.439 8.293 27.985 
Set 2 49.455 65 52.643 -6.882 2.066 -61.737 
Set 3 47.643 56.18 44.979 10.8 4.573 -15.613 
Set 4 43.584 61.743 28.979 60.137 -17.191 13.583 
AVERAGE 49.528 65.479 43.013 24.576 -0.221 -6.962 
SEM 2.527 4.016 4.288 12.708 4.926 17.15 
  
     
  
y-int -144.434           
slope 43.383   IC50 88 ug/ml   
R2 0.9           
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Table 8.20: The ELISA reading results of MDA-MB-157 cell numbers when treated 
with Propolis-2 and DMSO. Percent cell death and IC50 value were calculated 
according to this data.  
MDA-MB-
157 
Concentration (ug/ml) 
Propolis-2 30 37.5 60 75 120 150 
Set 1 0.983 0.782 0.684 0.371 0.138 0.181 
Set 2 0.88 0.905 0.953 0.742 0.341 0.287 
Set 3 0.828 1.086 1.097 0.841 0.445 0.478 
AVERAGE 0.897 0.924 0.911 0.651 0.308 0.315 
SEM 0.046 0.088 0.121 0.143 0.09 0.087 
  
     
  
MDA-MB-
157 
Concentration (ug/ml) 
DMSO 30 37.5 60 75 120 150 
Set 1 1.301 1.007 1.896 1.553 1.534 1.045 
Set 2 1.303 1.34 1.654 1.711 1.487 1.353 
Set 3 1.145 1.689 1.56 1.634 1.661 1.141 
AVERAGE 1.25 1.345 1.703 1.633 1.561 1.18 
SEM 0.052 0.197 0.1 0.046 0.052 0.091 
  
     
  
Percent Cell 
Death 
Concentration (ug/ml) 
30 37.5 60 75 120 150 
Set 1 24.443 22.344 63.924 76.111 91.004 82.679 
Set 2 32.464 32.463 42.382 56.634 77.068 78.788 
Set 3 27.686 35.702 29.679 48.531 73.209 58.107 
AVERAGE 28.24 31.301 46.506 60.135 80.269 73.305 
SEM 1.902 3.301 8.168 6.683 4.413 6.226 
  
     
  
y-int -86.302           
slope 33.19   IC50 61 ug/ml   
R2 0.94           
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Table 8.21: The ELISA reading results of BT-20 cell numbers when treated with 
Propolis-1 and DMSO. Percent cell death and IC50 value were calculated according 
to this data.  
BT-20  Concentration (ug/ml) 
Propolis-1 150 120 75 60 37.5 30 
Set 1 0.02 0.089 0.101 0.095 0.168 0.202 
Set 2 0.004 0.082 0.189 0.743 0.683 0.731 
Set 3 0.025 -0.011 0.566 0.4 0.91 0.642 
Set 4 0.028 0.303 0.51 0.759 0.87 1.013 
AVERAGE 0.019 0.116 0.342 0.499 0.658 0.647 
SEM 0.005 0.066 0.115 0.158 0.171 0.168 
  
     
  
BT-20  Concentration (ug/ml) 
DMSO 150 120 75 60 37.5 30 
Set 1 0.146 0.139 0.362 0.962 0.335 0.359 
Set 2 0.103 0.412 0.915 0.976 0.663 0.542 
Set 3 0.126 0.738 0.921 0.945 0.777 0.948 
Set 4 0.092 0.778 1.16 0.641 0.858 0.974 
AVERAGE 0.117 0.517 0.84 0.881 0.658 0.706 
SEM 0.012 0.15 0.169 0.08 0.115 0.152 
  
     
  
Percent Cell 
Death 
Concentration (ug/ml) 
150 120 75 60 37.5 30 
Set 1 86.301 35.971 72.099 90.125 49.851 43.733 
Set 2 96.117 80.097 79.344 23.873 -3.017 -34.871 
Set 3 80.159 101.491 38.545 57.672 -17.117 32.278 
Set 4 69.565 61.054 56.034 -18.409 -1.399 -4.004 
AVERAGE 83.761 77.563 59.286 43.36 0 8.357 
SEM 4.821 12.199 7.872 20.164 12.818 15.497 
  
     
  
y-int -181.212           
slope 53.877   IC50 73 ug/ml   
R2 0.94           
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Table 8.22: The ELISA reading results of BT-20 cell numbers when treated with 
Propolis-2 and DMSO. Percent cell death and IC50 value were calculated according 
to this data.  
BT-20  Concentration (ug/ml)   
Propolis-2 120 100 60 50 30   
Set 1 0.084 0.45 0.933 1.06 1.188   
Set 2 0.115 0.488 1.194 1.352 1.41   
Set 3 0.056 0.625 1.219 1.186 1.184   
AVERAGE 0.085 0.521 1.115 1.199 1.261   
SEM 0.017 0.053 0.091 0.085 0.075   
  
     
  
BT-20  Concentration (ug/ml)   
DMSO 120 100 60 50 30   
Set 1 0.161 1.154 0.961 0.991 1.168   
Set 2 0.139 1.537 0.817 0.525 0.546   
Set 3 0.416 0.876 0.694 0.596 0.509   
AVERAGE 0.21675 0.96525 0.6995 0.58725 0.61875   
SEM 0.089 0.192 0.077 0.145 0.214   
  
     
  
Percent Cell 
Death 
Concentration (ug/ml)   
120 100 60 50 30   
Set 1 47.826 61.005 2.914 -6.963 -1.712   
Set 2 
17.266 68.25 
-
46.144 
-157.524 -158.242 
  
Set 3 
86.538 28.653 
-
75.648 
-98.993 -132.613 
  
AVERAGE 60.784 46.024 -59.4 -104.172 -103.798   
SEM 16.63 10.12 19.559 36.089 39.62   
  
     
  
y-int -595.77           
slope 135.493   IC50 117 ug/ml   
R2 0.88           
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Table 8.23: The ELISA reading results of MDA-MB-361 cell numbers when treated 
with Propolis-1 and DMSO. Percent cell death and IC50 value were calculated 
according to this data.  
MDA-MB-361 Concentration (ug/ml) 
Propolis-1 15 20 30 40 60 80 
Set 1 1.109 1.177 0.827 0.918 0.692 0.549 
Set 2 1.923 1.847 1.143 0.857 0.954 0.981 
Set 3 2.292 1.497 1.469 0.842 1.11 0.084 
Set 4 2.292 1.711 0.969 1.161 1.138 0.779 
AVERAGE 1.904 1.558 1.102 0.945 0.974 0.598 
SEM 0.279 0.146 0.138 0.074 0.102 0.193 
  
     
  
MDA-MB-361 Concentration (ug/ml) 
DMSO 15 20 30 40 60 80 
Set 1 2.158 0.795 1.783 1.835 2.389 2.032 
Set 2 2.048 1.515 2.072 1.403 2.334 2.264 
Set 3 1.872 1.807 2.045 1.886 1.514 1.678 
Set 4 2.313 2.109 0.824 1.297 2.103 1.735 
AVERAGE 2.098 1.557 1.681 1.605 2.085 1.927 
SEM 0.093 0.281 0.293 0.149 0.2 0.136 
  
     
  
Percent Cell 
Death 
Concentration (ug/ml) 
15 20 30 40 60 80 
Set 1 48.61 -48.05 53.617 49.973 71.034 72.982 
Set 2 6.104 -21.914 44.836 38.917 59.126 56.67 
Set 3 -22.436 17.156 28.166 55.355 26.684 94.994 
Set 4 0.908 18.872 -17.597 10.486 45.887 55.101 
AVERAGE 9.247 -0.064 34.444 41.121 53.285 68.967 
SEM 12.82 14.16 13.825 8.679 8.253 8.039 
  
     
  
y-int -104.55           
slope 39.224   IC50 51 ug/ml   
R2 0.92           
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Table 8.24: The ELISA reading results of MDA-MB-361 cell numbers when treated 
with Propolis-2 and DMSO. Percent cell death and IC50 value were calculated 
according to this data.  
MDA-MB-
361 
Concentration (ug/ml) 
Propolis-2 30 37.5 60 75 120 150 
Set 1 0.455 0.317 0.219 0.401 0.127 0.03 
Set 2 0.779 0.797 0.489 0.692 0.432 0.053 
Set 3 1.757 1.289 0.724 0.471 0.39 0.059 
Set 4 1.748 1.353 0.622 0.489 0.269 0.099 
AVERAGE 1.185 0.939 0.514 0.513 0.305 0.06 
SEM 0.334 0.242 0.109 0.063 0.069 0.014 
  
     
  
MDA-MB-
361 
Concentration (ug/ml) 
DMSO 30 37.5 60 75 120 150 
Set 1 0.74 0.825 1.908 1.797 1.631 1.382 
Set 2 0.927 0.885 1.713 1.684 1.557 1.54 
Set 3 1.728 1.737 1.586 1.614 1.442 1.594 
Set 4 1.924 1.857 0.88 0.773 1.628 0.878 
AVERAGE 1.33 1.326 1.522 1.467 1.565 1.349 
SEM 0.292 0.273 0.224 0.234 0.044 0.163 
  
     
  
Percent Cell 
Death 
Concentration (ug/ml) 
30 37.5 60 75 120 150 
Set 1 38.514 61.576 88.522 77.685 92.213 97.829 
Set 2 15.965 9.944 71.454 58.907 72.254 96.558 
Set 3 -1.678 25.792 54.351 70.818 72.954 96.299 
Set 4 9.148 27.141 29.318 36.74 83.477 88.724 
AVERAGE 10.902 29.186 66.229 65.031 80.511 95.552 
SEM 7.425 9.431 11.004 7.828 4.114 1.799 
  
     
  
y-int -148.202           
slope 49.003   IC50 57 ug/ml   
R2 0.94           
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Table 8.25: The ELISA reading results of BT-474 cell numbers when treated with 
Propolis-1 and DMSO. Percent cell death and IC50 value were calculated according 
to this data.  
BT-474  Concentration (ug/ml) 
Propolis-1 30 37.5 60 75 120 150 
Set 1 1.454 1.752 0.715 0.779 1.04 1.433 
Set 2 1.878 0.402 0.119 0.51 1.517 0.682 
Set 3 0.547 1.032 1.333 0.702 0.138 -0.012 
AVERAGE 1.293 1.062 0.722 0.664 0.898 0.701 
SEM 0.393 0.39 0.35 0.08 0.404 0.417 
  
     
  
BT-474  Concentration (ug/ml) 
DMSO 30 37.5 60 75 120 150 
Set 1 2.128 1.787 1.21 1.612 1.697 1.734 
Set 2 2.317 2.219 1.176 0.728 2.337 1.015 
Set 3 2.744 2.19 1.989 1.73 2.464 2.679 
AVERAGE 2.396 2.065 1.458 1.357 2.166 1.809 
SEM 0.182 0.139 0.266 0.316 0.237 0.482 
  
     
  
Percent Cell 
Death 
Concentration (ug/ml) 
30 37.5 60 75 120 150 
Set 1 31.673 1.959 40.909 51.675 38.715 17.359 
Set 2 18.947 81.884 89.881 29.945 35.088 32.808 
Set 3 80.066 52.877 32.981 59.422 94.399 100.448 
AVERAGE 46.035 48.571 50.48 51.069 58.541 61.249 
SEM 15.218 19.093 14.576 7.298 15.688 21.075 
  
     
  
y-int 14.512           
slope 9.069   IC50 50 ug/ml   
R2 0.93           
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Table 8.26: The ELISA reading results of BT-474 cell numbers when treated with 
Propolis-2 and DMSO. Percent cell death and IC50 value were calculated according 
to this data.  
BT-474 Concentration (ug/ml)   
Propolis-2 30 60 75 120 150   
Set 1 0.513 0.418 0.45 0.172 0.064   
Set 2 0.508 0.91 0.911 0.384 0.157   
Set 3 0.346 1.081 0.835 0.134 0.088   
AVERAGE 0.456 0.803 0.732 0.23 0.103   
SEM 0.055 0.199 0.143 0.078 0.028   
  
     
  
BT-474 Concentration (ug/ml)   
DMSO 30 60 75 120 150   
Set 1 0.283 0.455 1.81 1.667 0.468   
Set 2 0.319 0.676 1.276 0.428 0.503   
Set 3 0.359 1.73 1.22 0.823 0.224   
AVERAGE 0.32 0.954 1.435 0.973 0.398   
SEM 0.022 0.393 0.188 0.365 0.088   
  
     
  
Percent Cell 
Death 
Concentration (ug/ml)   
30 60 75 120 150   
Set 1 -81.272 8.132 75.138 89.682 86.325   
Set 2 -59.248 -34.615 28.605 10.28 68.787   
Set 3 3.621 37.514 31.557 83.718 60.714   
AVERAGE -42.5 15.828 48.99 76.362 74.121   
SEM 20.787 17.454 12.334 21.299 6.204   
  
     
  
y-int -296.566           
slope 76.61   IC50 92 ug/ml   
R2 0.95           
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Table 8.27: The ELISA reading results of ZR-75-1 cell numbers when treated with 
Propolis-1 and DMSO. Percent cell death and IC50 value were calculated according 
to this data.  
ZR-75-1  Concentration (ug/ml) 
Propolis-1 120 100 80 75 60 50 
Set 1 0.064 0.039 0.097 0.365 0.563 0.914 
Set 2 0.006 0.39 0.749 1.636 1.658 2.378 
Set 3 0.025 0.758 0.946 1.697 2.067 2.441 
Set 4 0.031 0.99 0.931 1.955 2.009 2.378 
AVERAGE 0.032 0.544 0.681 1.413 1.574 2.028 
SEM 0.012 0.209 0.2 0.356 0.349 0.372 
  
     
  
ZR-75-1  Concentration (ug/ml) 
DMSO 120 100 80 75 60 50 
Set 1 2.009 2.511 2.554 2.452 2.159 2.369 
Set 2 2.105 2.543 2.458 2.518 2.548 2.307 
Set 3 1.679 2.233 2.137 2.668 2.483 2.505 
Set 4 1.498 1.15 1.728 1.975 2.099 2.386 
AVERAGE 1.823 2.109 2.219 2.403 2.322 2.392 
SEM 0.142 0.327 0.186 0.15 0.113 0.041 
  
     
  
Percent Cell 
Death 
Concentration (ug/ml) 
120 100 80 75 60 50 
Set 1 96.814 98.447 96.202 85.114 73.923 61.418 
Set 2 99.715 84.664 69.528 35.028 34.929 -3.078 
Set 3 98.511 66.055 55.732 36.394 16.754 2.555 
Set 4 97.931 13.913 46.123 1.013 4.288 0.335 
AVERAGE 98.245 74.206 69.311 41.199 32.214 15.217 
SEM 0.523 16.146 9.443 14.988 13.147 13.349 
  
     
  
y-int -349.542           
slope 93.018   IC50 73 ug/ml   
R2 0.94           
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Table 8.28: The ELISA reading results of ZR-75-1 cell numbers when treated with 
Propolis-2 and DMSO. Percent cell death and IC50 value were calculated according 
to this data.  
ZR-75-1   Concentration (ug/ml)   
Propolis-2 120 100 60 50 25   
Set 1 0.103 0.049 0.589 0.526 0.701   
Set 2 0.125 0.08 0.635 0.684 0.755   
Set 3 0.078 0.271 0.681 0.785 0.838   
AVERAGE 0.102 0.133 0.635 0.665 0.765   
SEM 0.014 0.069 0.027 0.075 0.04   
  
     
  
ZR-75-1   Concentration (ug/ml)   
DMSO 120 100 60 50 25   
Set 1 0.198 0.091 0.94 1.066 0.93   
Set 2 0.32 0.409 1.258 1.318 0.886   
Set 3 0.191 0.716 0.958 1.139 0.72   
AVERAGE 0.236 0.405 1.052 1.174 0.845   
SEM 0.042 0.18 0.103 0.075 0.064   
  
     
  
Percent Cell 
Death 
Concentration (ug/ml)   
120 100 60 50 25   
Set 1 47.98 46.154 37.34 50.657 24.624   
Set 2 60.938 80.44 49.523 48.103 14.786   
Set 3 59.162 62.151 28.914 31.08 -16.389   
AVERAGE 56.78 67.16 39.639 43.356 9.467   
SEM 3.319 8.18 4.894 5.017 10.107   
  
     
  
y-int -93.951           
slope 33.28   IC50 76 ug/ml   
R2 0.89           
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Table 8.29: The ELISA reading results of hTERT-HME1 cell numbers when treated 
with Propolis-1 and DMSO. Percent cell death and IC50 value were calculated 
according to this data.  
hTERT-HME1 Concentration (ug/ml) 
Propolis-1 25 30 50 60 100 120 
Set 1 0.118 0.05 0.05 0.039 0.036 0.045 
Set 2 0.548 0.557 0.624 0.093 0.041 0.092 
Set 3 0.893 0.719 0.538 0.387 0.153 0.087 
Set 4 0.723 0.713 0.371 0.155 0.082 0.087 
AVERAGE 0.571 0.51 0.396 0.169 0.078 0.078 
SEM 0.166 0.158 0.127 0.077 0.027 0.011 
  
     
  
hTERT-HME1 Concentration (ug/ml) 
DMSO 25 30 50 60 100 120 
Set 1 0.237 0.304 0.272 0.922 1.02 0.399 
Set 2 0.85 0.78 0.909 1.161 1.048 0.38 
Set 3 0.889 1.065 1.091 1.15 1.122 0.542 
Set 4 1.093 1.219 1.099 0.389 0.251 0.152 
AVERAGE 0.767 0.842 0.843 0.906 0.86 0.368 
SEM 0.185 0.201 0.195 0.181 0.204 0.081 
  
     
  
Percent Cell 
Death 
Concentration (ug/ml) 
25 30 50 60 100 120 
Set 1 50.211 83.553 81.618 95.77 96.471 88.722 
Set 2 35.529 28.59 31.353 91.99 96.088 75.789 
Set 3 -0.45 32.488 50.687 66.348 86.364 83.948 
Set 4 33.852 41.509 66.242 60.154 67.331 42.763 
AVERAGE 25.554 39.43 53.025 81.347 90.93 78.804 
SEM 9.338 11.055 9.368 7.789 5.99 9.075 
  
     
  
y-int -91.469           
slope 38.216   IC50 41 ug/ml   
R2 0.84           
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Table 8.30: The ELISA reading results of hTERT-HME1 cell numbers when treated 
with Propolis-2 and DMSO. Percent cell death and IC50 value were calculated 
according to this data.  
hTERT-
HME1 
Concentration (ug/ml) 
  
Propolis-2 37.5 60 75 120 150   
Set 1 0.684 0.638 0.516 0.216 0.093   
Set 2 0.679 0.636 0.561 0.314 0.097   
Set 3 0.379 0.581 0.585 0.434 0.066   
AVERAGE 0.581 0.618 0.554 0.321 0.085   
SEM 0.101 0.019 0.02 0.063 0.01   
  
     
  
hTERT-
HME1 
Concentration (ug/ml) 
  
DMSO 37.5 60 75 120 150   
Set 1 0.421 0.565 0.839 0.252 0.255   
Set 2 0.516 1.059 0.874 0.576 0.275   
Set 3 0.59 1.13 0.591 0.524 0.288   
AVERAGE 0.509 0.918 0.768 0.55 0.273   
SEM 0.049 0.178 0.089 0.1 0.01   
  
     
  
Percent Cell 
Death 
Concentration (ug/ml)   
37.5 60 75 120 150   
Set 1 -62.47 -12.92 38.498 14.286 63.529   
Set 2 -31.589 39.943 35.812 45.486 64.727   
Set 3 35.763 48.584 1.015 17.176 77.083   
AVERAGE -14.145 32.68 27.865 41.636 68.864   
SEM 23.729 15.844 9.888 9.346 3.539   
  
     
  
y-int -190.891           
slope 50.9   IC50 114 ug/ml   
R2 0.88           
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8.2 Documents of Permission to Reuse of Figures 
 
 
Figure 8-1 Permission to Reuse of Figure 1-1. 
 
 
Figure 8-2 Permission to Reuse of Figure 1-2. 
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Figure 8-3 Permission to Reuse of Figure 1-3. 
 
 
Figure 8-4 Permission to Reuse of Figure 1-4. 
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Figure 8-5 Permission to Reuse of Figure 1-5. 
